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This study describes the synthesis and characterization of a new receptor (cyclen 1) 
capable of strong selective binding of pyrene-based anionic dyes under near-physiological 
conditions.  This receptor comprises four naphthylthiourea groups tethered to a cyclen core via 
an ester linkage.  The most important finding was the ability of cyclen 1 to bind efficiently to a 
pH-sensitive pyranine dye, a dye that is commonly used in various biomembrane assays.  The 
high affinity of cyclen 1 to pyranine, its impermeability to the lipid bilayer membrane, fast 
kinetics of binding, and ability to quench pyranine’s fluorescence were used as a basis for a new 
membrane leakage assay.  This membrane leakage assay is fully compatible with the commonly 
xxiv 
 
 
 
applied pH-stat transport assay, and therefore it allows for differentiation of ion transport and 
nonselective leakage mechanisms within a single set of experiments. 
In the second part of this study a new methodology for the detection of lipid flip was 
developed.  This methodology relies on the quenching of the fluorescence of a newly synthesized 
cascade-blue-labeled lipid through complex formation with cyclen 1.  This receptor-dye 
complexation also has high affinity for binding at micromolar concentrations and can be reversed 
by either competitive displacement of the lipid probe or by enzymatic degradation of the receptor 
leading to the label release and fluorescence dequenching.  This new methodology is suitable for 
the study of lipid flip in both model spherical bilayer membranes and in-vitro experiments, and is 
less invasive to the model and cell membranes than the commonly utilized 7-nitro-1,2,3-
benzoxadiazol-4-yl (NBD)-dithionite methodology. 
Lastly, new pH-sensitive lipids were synthesized and utilized in the formulation of 
liposomes suitable for controlled drug release.  These liposomes contain various amounts of 
internal NaCl and undergo internal acidification upon the exogenous addition of an HCl co-
transporter in a physiologically relevant NaCl solution.  Therefore, acidification ultimately leads 
to the hydrolysis of the pH-sensitive lipids and subsequent contents release.  These liposomes 
were found to be insensitive to physiological concentrations of human serum albumin and to be 
non-toxic to cells at concentrations exceeding pharmacological relevance.  These results render 
this new drug release model potentially suitable for in vivo applications. 
 
  
 
 
 
 
 
Chapter 1 
 
Introduction 
1.1 Introduction to Biomembranes 
Biological membranes are one of the smallest and yet most complex building blocks in 
human organisms and the very basis of life as we know it.
1
  These membranes provide a 
structural barrier that separates the intracellular components from their extracellular 
surroundings.  The selectively permeable cell walls are comprised of amphiphilic lipid molecules 
that contain a polar head group and a nonpolar hydrophobic tail.  These lipids comprise the 
structural component of the phospholipid bilayer (Figure 1.1).  Embedded within the lipid 
bilayer are functional components consisting of specialized proteins that are capable of a vast 
range of cellular processes, including cell 
signaling for cell adhesion, cell division, 
and transport of nutrients.
2
  These highly 
specialized proteins enable and control the 
selective diffusion of biomolecules and ions 
(including food intake and waste excretion), 
which is critical for cell survival.
3
  Cells 
control these movements through 
transmembrane protein complexes, which 
Figure 1.1: Simplified Depiction of Bilayer 
Membrane 
Polar Head
Apolar Tail
Amphiphilic Lipid
Molecule
 2 
 
can form gated pores (discussed in detail in Section 1.3.1).
4
  Additionally there are multiple 
enzymes within these membranes such as flippases, floppases and scramblases which are 
responsible for cell signaling and membrane asymmetry (discussed in Section 1.3.3).
5
   
Further elucidation and understanding of the mechanisms for these protein activities have 
become a primary goal of many research groups.  As a result of this research, the way that 
scientists perceive and view the cellular membrane is constantly evolving.
6
  Even over the last 
two decades cellular information has dramatically changed due to the newly recognized capacity 
for biomembranes to partition and form transient domains.
6
  Research has shown that 
biomembranes are naturally asymmetric in their shape and lipid composition,
7
  and that within 
cells there are aggregates of specific proteins that are responsible for critical cellular processes 
and functions.  Some of these functions include cell formation and division, apoptosis,
8
 transport, 
cell trafficking,
9
 and endocytosis,
10
 all of which are briefly discussed in Section 1.2.  All of these 
cellular activities are of particular interest because of their direct involvement in several disease 
processes, known as channelopathies, which are discussed in Section 1.3.2.   
The vast complexity of biomembranes and their respective cellular functions have 
necessitated the analysis of secondary complexes and subsystems within biological membranes.  
This breakdown of the cell into smaller, simpler entities for study, has led to membrane models 
and mechanistically specific assays.  The development of several model cellular systems, such as 
patch clamp and planar lipid bilayer systems (Section 1.5)
11
 have enabled scientists to gain 
invaluable insight into the mechanism of critical biomembrane processes.  In order to determine 
more information about complicated cellular functions, researchers have utilized liposomes, 
which are extremely simplified cell models (Section 1.4).
12
  Within these liposomal systems 
 3 
 
scientists can control a variety of factors including size, lipid and protein composition, and intra- 
and extracellular composition.  However, even within these model systems, the ability to 
accurately monitor cellular activities and functions as well as to decipher the mechanisms 
through which they take place remains as a challenging undertaking. 
1.2 Introduction to Highly Specific Membrane Functions 
 The strict regulation of cellular processes is vital for cell survival, including the formation 
of new cells through cell division (mitosis and cytokinesis), fusion of cells, endocytic uptake and 
exocytic release of molecular compounds, and apoptosis.  Within all of these processes, 
biomembrane activity plays a central role.  Although there are a multitude of cellular functions, 
only the ones that are relevant to the present studies will be introduced. 
 1.2.1 Biomembrane Rafts and Caveola Domains 
 As depicted in Figure 1.1, cells consist of a bilayer membrane that contains an inner and 
outer ‘leaflet’ as well as an internal aqueous compartment.  These bilayer membranes are 
composed of multiple lipids and membrane bound proteins, which are not symmetrically 
distributed throughout the bilayer membrane.  The primary components that comprise this 
bilayer membrane include glycosphinogolipids, sphinogolipids, and cholesterol.
13
  Research has 
led to the discovery of aggregates of particular lipids and proteins to form transient “domains” or 
“lipid rafts”6, 10 within these bilayers, which have been associated with multiple cell trafficking 
and signaling pathways.
10, 13
  This area is still highly debated, although it is generally accepted 
that these small microdomains persist between nanoseconds to minutes depending on their size 
and function.
13
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Recently, much research has been devoted to the study of caveolae
14
 (a subset of lipid 
rafts) for their role in molecular transport, internalization and endocytic pathways, and signal 
transduction.
10
  First presented by Palade and Yamada in the 1950’s, caveolae are known for 
their flask-like invaginations, which are capable of acting as vesicle transporters.
15
  Both 
caveolae and lipid rafts are often analyzed after isolation by either detergent-based or non-
detergent based methods;
13
 however, it is arguable that after these microdomains have been 
removed, they are no longer representative of intact cellular rafts.
10
  Therefore, the need for in 
situ lipid probes is paramount in order to accurately define these domains.
16, 17
  Currently, the 
most common methods for detecting and studying lipid domains are atomic force microscopy 
(AFM)
17-20
 and fluorescent probes.
16, 21-23
 
 1.2.2 Endocytosis and Exocytosis 
 In the most general sense, endocytosis refers to the ability of a cell to uptake molecular 
components (proteins, lipids, drugs etc.) through encapsulation within an endovesicle in the 
cell.
24
  The term ‘endovesiculation’ refers to the same process but within vesicles or model 
membranes instead of live cells.
25
  Endocytosis is important due to its association with lipid and 
protein trafficking.
26-28
  Although the most common type of endocytosis is clathrin-mediated, 
recent work has led to the discovery of ‘clathrin-independent pathways’.29, 30  Even though the 
exact mechanisms and function of caveolae are not fully understood, it is known that they 
participate in endocytosis
31
 as well as transcytosis (transport across cell layer) of important 
proteins across the endothelial barrier.
32
  Whereas endocytosis refers to the uptake of molecular 
components, exocytosis refers to the excretion or efflux of molecular compounds as well as 
unwanted debris.
33-35
  During caveolar exocytosis a complex protein mechanism leads to the 
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fusion of an intracellular vesicle with the cytosolic side of the biomembrane and the eventual 
release of vesicle contents to the extracellular surroundings.
36, 37
  Current methodologies for 
monitoring exocytosis include patch clamp, fluorometry and ultramicroelectrode electrochemical 
techniques.
37
  Recent review articles give detailed descriptions of both the intracellular as well as 
the intercellular models for signaling by caveolae
38
 and their monitoring by fluorescence.
39, 40
    
 1.2.3 Apoptosis 
Apoptosis, or programmed cell death, is an extremely important, highly regulated and 
complicated process that is necessary for the control and removal of damaged or surplus cells.
41
  
By definition this genetic process is “characterized morphologically by membrane blebbing, 
chromatin condensation, loss of cell volume and DNA fragmentation, and biochemically by 
caspase activation.”42  It has been found that suppression, overexpression, and mutation of the 
genes that trigger and coordinate the apoptotic cascade are associated with several disease 
processes, including inflammation, cancer, autoimmune disorders, Alzheimer’s and Parkinson’s 
disease to name just a few.
41, 43
  Therefore, there is a strong desire among the scientific and 
medical community to determine not only the mechanisms by which these processes occur but 
also how to correct this mechanistic malfunction.  Apoptosis is also commonly studied by 
Western blotting, cytometry, and fluorescence spectroscopy.
44-49
 
1.3 Mechanisms and Implications of Molecular Ion Activity in Membranes 
 1.3.1 Mechanisms for Biomembrane Transport 
In addition to the transient lipid domains responsible for membrane signaling, trafficking, 
and molecular transport, there are also more established and persistent modes for the transport of 
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ions and small polar molecules.  The movement of ions and molecules across lipid membranes is 
extremely vital for cellular functions as well as for cell survival, and therefore, it is important to 
study these processes and learn more about the mechanisms through which they take place.  Both 
the mechanism (how ions cross the bilayer) and the stoichiometry of transport (number of ions 
being shuttled) are of interest in ion transport studies.   
Ion transport commonly takes place via one of two mechanisms: 1) mobile “carriers” or 
2) ion channels, which are illustrated in Figure 1.2.
50-52
  In the mobile carrier mechanism an 
ionophore shuttles ionic substrates from one side of the membrane to the other (Figure 1.2A).  In 
the context of this work, ionophores are defined as membrane soluble molecules that are capable 
of transporting specific ions and molecules across the hydrophobic bilayer membrane.
53
  
Although there is a large energy barrier for the transport of hydrophilic ions such as Na
+
, K
+
, 
Ca
+2
 and Cl
-
, their transport is easily accomplished with the aid of ionophores, which shield their 
electrostatic charges from the bilayer membrane.
54
  The second mode of transport via ion 
channels (Figure 1.2B) facilitates ion transport by self-assembling necessary components that 
result in the formation of a tunnel or pore within the membrane.
55
  This tunnel enables the ions to 
pass through the bilayer in essentially extracellular fluid without being exposed to any 
hydrophobic constituents.  Whereas the mobile carriers control movement of the substrates 
through recognition and signaling, the ion channels are “gated,” meaning they operate under an 
open-close process in response to some cellular event.
11
  The stimuli that can initiate this gating 
process are mechanosensitive (physical stimuli), ligand-gated (extracellular chemical stimulus), 
signal-gated (intracellular stimulus) and voltage-gated channels (membrane potentials).
56
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Finally, the stoichiometry of ion transport must be considered.  It is important to note that 
within these mechanisms more than one substrate can be shuttled at a time.  Therefore, it is 
useful to describe the mediated transport process as a uniport, symport or antiport translocation 
system.  Uniport denotes an ionophore that translocates one substrate at a time, as shown in 
Figure 1.3A, whereas symport represents the simultaneous translocation of two different ions or 
molecules (Figure 1.3B).  Antiport can be extremely important in counterbalancing ion transport 
by transporting two different molecules in opposite directions within the bilayer (Figure 1.3C).  
 8 
 
 
Figure 1.2: Ion Transport Mechanisms: (A) Illustration of the mobile carrier 
mechanism.  Substrate is able to move through the bilayer through recognition, 
encapsulation and shielding by the carrier molecule. (B) Depiction of an ion channel.  
Substrate moves directly through the hydrophobic membrane via an open channel that 
can regulate flow. 
Figure 1.3: Translocation Systems: (A) Uniport – only one molecule is transported 
through bilayer membrane.  (B) Symport – two different molecules are transported 
through membrane in the same direction.  (C) Antiport – two different molecules are 
transported in opposing directions through the bilayer membrane. 
A.) Uniport B.) Symport C.) Antiport
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1.3.2 Channelopathies 
There is a strong desire among the scientific community to gain more understanding and 
insight into the specific mechanisms of ion transport, as well as the resultant functions that occur 
as an outcome of the ion transport.  As previously stated, the transport of ions across membranes 
affects a multitude of cellular operations that are essential for the existence and proper function 
of the cell.  Dysfunction within these transport mechanisms can lead to wide-ranging diseases, 
commonly referred to as “channelopathies.”52, 57  For example, the movement of sodium and 
potassium ions is crucial for nerve functioning.
58
  A decrease in cellular K
+
 levels has been 
suggested to trigger apoptotic death, whereas increased cytosolic Ca
+2
 levels can lead to suicidal 
erythrocyte death.
59
  Epilepsy is a neurodegenerative disease that results from mutations in 
voltage-gated Na
+
, K
+
, Ca
+2
, or Cl
-
 channels.
60
  Mutations of the cystic fibrosis transmembrane 
conductance regulator (CFTR) protein lead to reductions in Cl
-
 and water secretions in epithelial 
airway surfaces, as well as the inability to absorb Na
+
 and water from airway surfaces.
61-63
  This 
irregularity in ion transport leads to the removal of salt and water from airway passages, which 
results in the buildup of gylcoproteins in the mucus layer.
61-63
  These examples alone illustrate 
the crucial importance for understanding how biomembranes operate and function and therefore 
the requirement for highly sensitive and specific methods for monitoring these systems.  The 
currently utilized methods for monitoring these events are summarized in Section 1.6.   
  1.3.3 Enzymes that Regulate Membrane Asymmetry 
 Although it may not seem directly related at first glance, the enzymes that regulate 
membrane asymmetry are essential for the transport of ions and molecules throughout the cell.  It 
has been noted that asymmetric phospholipid distribution is vital for cell survival and can affect 
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ion channel shape and size and ionophoretic activity as well as protein signaling, fusion, blood 
coagulation, and apoptosis.
 64-73
  Research has shown that the outer leaflet of eukaryotic cells are 
enriched with phosphatidylcholine (PC) and sphingomyelin (SM), whereas the endoplasmic 
leaflet is concentrated with the phosphatidylethanolamine (PE) and phosphatidylserine (PS) 
(Figure 1.4).
74
  The approximate distribution of phospholipids between the inner and outer 
leaflets of an erythrocyte membrane is presented in Figure 1.5.
75
   
Figure 1.4:  Structures of Common Phospholipids 
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Phospholipids both move laterally throughout a bilayer leaflet as well as diffuse between 
the two leaflets, with the latter being the more time and energy consuming process.
5, 76
  There are 
natural enzymes that can catalyze these processes, known as flippases, floppases and scramblases 
which are shown in Scheme 1.1.
77
  In the case of flippases, phospholipids are translocated or 
“flipped” from the outer bilayer leaflet into the cytosolic leaflet.78  Floppases do the exact 
opposite, by transporting or “flopping” lipids from the internal leaflet into the external bilayer.2, 
74
  Both of these processes are energy (ATP) dependent, whereas scramblases are energy 
independent and move any phospholipids down its concentration gradient.
2, 74, 78
  Specifically, 
scramblase activity leads to the controlled movement of lipids to areas within the bilayer that 
have a lower concentration of that particular lipid (toward equilibrium), either laterally or 
between the two bilayer leaflets.
3
   This activity is increased in the presences of Ca
2+
.
2, 74, 78
   
Figure 1.5: Distribution of Phospholipids Across an Erythrocyte Membrane
*
 
* 
Reprinted with permission from Daleke, D. L. Curr. Opin. Hematol. 2008, 15, 191.  Copyright 2008 
Lippincott Williams & Wilkins 
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The loss of asymmetry within a membrane can occur in both normal and pathologic 
situations.
74
  For example, the controlled movement of PS to the cytosolic leaflet is a trigger for 
cell death and subsequent removal by phagocytosis,
2, 79
  while the unregulated translocation of 
PS to the outer leaflet can contribute to cardiovascular diseases, stroke and diabetes.
74
   
Therefore, synthetic molecules
80-83
 and peptide analogs
84, 85
 capable of lipid flipping can be 
considered as developmental therapeutics for several specific disorders
86, 87
 such as Scott 
syndrome and vascular complications in Alzheimer’s disease.88, 89  Furthermore, flip of cationic 
lipids may greatly improve the efficiency of non-viral gene delivery systems.
90
  Consequently, 
lipid flip detection assays, which allow the monitoring of the activity of these enzymes and their 
analogs, are in high demand.  The currently utilized assays are introduced in the following 
section (1.5) along with the inherent deficiencies that lead to the need for new assays.  
Scheme 1.1: Enzyme Promoted Flip Flop in a Bilayer Membrane 
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1.4 Application of Liposomes as Model Membranes 
As previously mentioned, membranes not only provide the structural barrier of cells but 
they are also responsible for multiple cellular functions.  Biomembranes include a number of 
lipids and phospholipids, which consist of three main groups, the glycerol-based lipids, 
cholesterol and sphingoid-based lipids.
91
  Biomembrane systems also contain proteins that are 
responsible for cell transport and cell-signaling.  Due to the diverse complexity of these 
biomembranes, it is often desirable to have a simpler model when studying particular elements.  
The implementation of model membranes, known as liposomes or vesicles (used 
interchangeably), was first recognized in 1965 by Bangham.
92, 93
  Since their establishment, 
liposomes have been employed in drug delivery, gene therapy, disease treatment, immunoassays 
and many more areas that have been subject of many excellent review articles.
12, 94-97
   
Liposomes are similar to cell membranes since they can be formulated to contain a 
bilayer membrane; however, the internal and external contents can be controllably altered with 
respect to the number of lipids, proteins and enzymes they contain.  These bilayers can be 
tailored to differing levels of complexity; from only one type of phospholipid with no proteins to 
multiple types of lipids and proteins.   They can also be custom-made to contain one bilayer, 
known as unilamellar, or multiple layers like that of an onion, known as multilamellar.  Typical 
sizes range from anything less than 100 nm in diameter in small unilamellar vesicles (SUVs) to 
anywhere between 100 nm and 1000 nm for large unilamellar vesicles (LUVs).
94, 98
  Giant 
unilamellar vesicles (GUVs) are considered to be larger than 1000 nm. 
94, 98
    
Within the studies described in this work, we utilized LUVs that are approximately 120-
130 nm in size which have been prepared by high pressure extrusion and contain egg yolk 
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phosphatidylcholine (EYPC).
99, 100
  [The predominant species in the EYPC was C42H82NO8P, 
18:1 (Δ9).]  In this approach, initial formation of LUVs is accomplished through the addition of 
aqueous buffer to the desired solution of phospholipids, which are dissolved in an organic 
solvent.  After mixing the contents the organic solvent is removed under reduced pressure to 
form a thin film.  The desired  internal aqueous solution is then added and a series of freeze-thaw 
cycles generally form LUVs, whose size is altered through high pressure extrusion through a 
polycarbonate membrane of a defined pore size.
100
 
1.5 Current Methodologies for Monitoring Membrane Transport/Activity 
 This first chapter has only briefly introduced the plethora of possible methods by which 
substrates are transported across a bilayer membrane.  One can therefore imagine that there is an 
immense need for multiple, highly sensitive, versatile assays to monitor not only whether 
transport is taking place but also the mechanisms by which the transport occurs.  In Section 1.3 
some of the various mechanisms by which ions, lipids and substrates are transported across a 
biological membrane were introduced.  It is important to note that various methodologies are 
currently employed for studying biomembrane events; however, each one of these methods 
contains imperfections and sometimes even discrepancies with results from alternative methods.  
The remainder of this section will be devoted to briefly describing various methodologies for the 
detection of ion transport and the mechanisms through which it occurs, as well as, lipid flip 
activity. 
 1.5.1 
23
Na NMR   
NMR spectroscopy can be utilized for determining the activity of ionophores in vesicles.  
The major advantage to using NMR spectroscopy is that it is a direct method of analysis, in 
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contrast to fluorescent studies, which commonly use a pH sensitive dye such as 8-
hydroxypyrene-1,3,6-trisulfonate (HPTS, pyranine) to indirectly monitor the movement of ions 
through a bilayer membrane.  Additionally, NMR is advantageous for in vivo studies due to its 
non-invasive nature.
101
  Researchers including Regan
102
, Riddell
103
 and Gupta
104
 have developed 
a series of NMR experiments that can directly measure the transport of ions by tuning the NMR 
probe to 
7
Li, 
23
Na, 
39
K, and 
35
Cl. 
 The most commonly used NMR transport experiments follow the transport of sodium 
ions.  In a typical 
23
Na NMR experiment, a set of vesicles is formulated with the same amount of 
internal vs. external Na
+
 ions.
105
  In order to discern the difference between the intracellular and 
extracellular NMR signals, the addition of a membrane impermeable shift reagent containing 
(Dy
3+
)
102, 104, 106-108
, (Gd
3+
)
104, 109-111
 or (Tm
3+
)
112-115
   on either side (internal or external) of the 
liposomes is necessary.  Complexation of the shift reagent with 
23
Na
+
 ions allow for a chemical 
shift difference to occur between the free and the bound 
23
Na
+
 ions.  Furthermore, the addition of 
a membrane active ionophore will lead to exchange of 
23
Na
+
 ions within the two environments 
and a corresponding change in the NMR signals.
51
   
 Although dynamic NMR spectroscopy can be an extremely efficient method for 
determination of the activity of ionophores, it also contains many inherent deficiencies.  It is a 
time-consuming process that necessitates extensive initial training for the researcher, a 
significant amount of time to gather real-time data for the ionophoretic activity, and a high cost 
for the chemical shift agents.  The analysis of 
23
Na
+
 ions is convenient because of its large 
magnetogyric ratio, moderate quadrupole moment and large natural abundance (100%).
116
  
However, if studies require the analysis of the transport of other ions such as (Li
+
)
117-121
, (K
+
)
122-
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126
 or even (Cl
-
),
127-129
 this can become increasingly cumbersome and time consuming due to any 
combination of factors such as competitive binding, different magnetogyric ratios and/or lower 
natural abundances.
130
  It has also been shown that this technique can be somewhat “user” 
dependent and results can vary between repeated experiments.
11
  This method can be very good 
for determining whether or not ion transport is taking place; however, it is less amenable to 
kinetic studies.
51
  It has also been shown that certain chemical shift reagents can be toxic
131
 and 
disruptive toward liposomes, leading to fusion
129, 132
 or rupture
129, 133
 of vesicles.  The potential 
for competitive sodium binding with substrates other than the shift reagent must also be 
considered.
134
  Lastly, the analysis of the kinetics of binding can also be problematic if they 
occur too fast on the NMR timescale.
129
 
 1.5.2 Conductance Methodologies: Voltage Clamp, Patch-Clamp, Planar Bilayer 
Voltage Clamp   
The voltage clamp method was invented in the 1950’s through a compilation of research 
by different people.
135
  Most notable of all this work was probably that of Alan Hodgkin and 
Andrew Huxley, who carried out a series of experiments that led to the discovery of electric 
current in cell membranes for which they were awarded a Nobel Prize for Physiology or 
Medicine in 1963.
136
  Briefly, the voltage clamp method contains two sharp tip electrodes, one of 
which remains in the extracellular matrix and another that pierces the cell membrane placing it in 
the cell cytoplasm.
136
  Having an electrode in two different cellular environments allows for any 
differences in impulse generation to be recorded.  The inherent disadvantages with this method 
are the excessive background noise and the fact that physiological conditions are altered by 
piercing the membrane with the electrode.   
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This significant milestone in electrophysiology was revolutionized in the 1960’s when 
Erwin Neher and Bert Sakmann developed the patch clamp technique, work which was also 
recognized with the Nobel Prize for Physiology or Medicine in 1991.
137, 138
  The patch clamp 
method has been extensively applied to the study of ionophores and is considered to be one of 
the most predominant methods.
139-141
   
Neher and Sakmann were able to avoid the disadvantages of the voltage clamp method by 
using a metal coated glass pipette that forms a tight seal with the bilayer membrane.
137
  The 
electrical properties of this tight seal range on the order of 10
10
 Ohms and is referred to as a 
“gigaseal.”137  The gigaseal drastically decreases background noise, increases sensitivity of 
measurements, and can allow measurements within either the whole-cell or a selected, excised 
patch of the membrane.  During these experiments, researchers can monitor either all channel 
activity or single ion movement between the bilayer membrane and the pipette, depending on the 
chosen recording configuration.  An excellent review by Liem et al. summarizes a series of 
available experimental protocols within this design.
140
  The resultant spectra from ion channel 
behavior (open and close functions) are recorded as a square wave function.
11
     
One of the largest limitations of the patch clamp method is the large time requirement
142
 
for experiments as well as the need for a highly trained and experienced operator.
143
  Within 
certain protocols of the patch-clamp experiment, drawbacks can include the release and 
exchange of interior cell contents, such as organelles and ionophores of interest, into the pipette 
or bath solution.
140, 144
  Additionally, it is possible to obtain erroneous recordings of channel 
activity or results that may not be reflective of the entire cell.
140
  Some researchers also believe 
that the stress placed on the membrane in a patch clamp experiment can lead to inaccurate 
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results.
145
  However, even with these possible drawbacks this method is still considered to be a 
gold-standard, yielding invaluable information about channel activity.
 70,156
  
Due to the need for experiments with higher-throughput and higher sensitivity, there have 
been a series of advances that have yielded vast improvements within this technique.
52, 141
  One 
such advancement was the development of planar bilayer voltage clamp (PBVC) experiments, 
which utilize two separate buffer-containing cells (containing Ag/AgCl reference electrodes) that 
are connected by a small pinhole.
11, 146
  The bilayer membrane is then ‘painted’ onto this small 
aperture.  Although there are fewer configurations within this method than the patch-clamp 
technique, the internal and external solutions can be exchanged very readily.  Recently there has 
been a strong push to develop higher-throughput systems using chip-based PBVC platforms.
147
 
   1.5.3 Liposome Based pH-stat Fluorometric Assay 
One commonly utilized assay for the detection of physiologically relevant ionophore 
activity is the liposome based pH-stat fluorometric assay.  This assay monitors the fluorescence 
intensity of a pH-sensitive dye, usually 8-hydroxypyrene-1,3,6-trisulfonate (HPTS, pyranine) 
shown in Scheme 1.2A, but sometimes fluorescein.
148-152
  Pyranine is advantageous for studying 
biological systems since its pKa (7.2) is close to that of physiological pH.
153
  Additionally, the 
protonated and deprotonated forms of this dye are excited at different wavelengths (405 and 460 
nm respectively) but both emit at the same wavelength (510 nm).
153
  Therefore, the indirect 
monitoring of the fluorescence ratio of the protonated: deprotonated forms of pyranine dye can 
reveal the pH of a solution.
153, 154
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In this experiment (Scheme 1.2B), a controlled amount of base and a potential ionophore 
are added to a suspension of liposomes that have been preloaded with HPTS dye (100 μM).155  
The addition of the external base leads to a difference in the intra- and extravesicular pH, 
resulting in a gradient across the bilayer membrane, which leads to the efflux of hydronium ions.  
The resultant buildup of electrostatic potential can be compensated for by either the influx of 
cations or the efflux of anions from the liposomes.  If the compound of interest mediates such ion 
transport, the efflux of hydronium ions continues altering the intravesicular pH and the 
fluorescence of the reporter dye.  The kinetic trace obtained from the dye response thus reflects 
the ionophoretic activity of the studied compound.  While the major advantage of this method is 
its rapid and reliable results, the pH-stat assay provides little information on the mechanism of 
ion transport.
1
  One can only determine whether or not an ionophore is properly functioning.  
Also, the results of the pH-stat assay do not always correlate with other methods of study.
156-158
  
Scheme 1.2:  pH-Stat Experiment: (A) Structure of pyranine dye. (B) The 
fluorescence of the pH-sensor pyranine in liposomes is monitored as a function of 
time; the H
+ 
release is a result of exogenous application of the base and ionophore. 
B. A. 
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 1.5.4 Calcein Based Assay 
Although the pH-stat assay lacks details on the mechanism of ion transport, a membrane 
leakage assay can reveal some mechanistic aspects by distinguishing selective ion transport from 
nonselective leakage through oversized pores.  This assay utilizes the fluorescent dyes, shown in 
Scheme 1.3A, calcein or carboxyfluorescein (CF) and its fluorescent self-quenching which 
occurs at very low concentrations (approximately 100 mM).
159, 160
   
In a typical experiment (Scheme 1.3B), a set of liposomes containing the concentrated 
dye is challenged with the ionophore of interest.  This assay is crucial for determining whether or 
not an ionophore is acting by means of selective ion leakage or through massive leakage through 
large pores.  In the case of selective ion transport, little change in fluorescence is observed, since 
the larger calcein dye will not likely be transported by selective ionophores.  However, larger 
pore formation, such as that arising from introduction of melittin,
161
 results in the release of dye, 
its subsequent dilution, and an emission increase.  Therefore this assay can reveal limited 
calcein calcein
calceincalcein calcein
calcein calcein
la
rg
e
 p
o
re calcein
calcein
calcein
Scheme 1.3: Membrane Leakage Assay: (A) Structure of calcein dye. (B) 
LUVs containing calcein are probed with the ionophore.  In the case of large 
pore formation, the self-quenching dye is released and restores the emission. 
B. A. 
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information about the size and selectivity of channel activity in the specific case of large pore 
formation.  However, whereas the pH-stat assay is based on LUVs containing the dye at low 
concentration (100 μM), the high concentration of the dye in the membrane leakage assays (100 
mM) could alter the bilayer properties, change the buffer capacity, and interact with the 
ionophore.  For optimal compatibility and reliability, the same LUVs should be utilized in both 
pH-stat and membrane leakage assays. 
 1.5.5 Endovesiculation Studies with DPX 
A similar problem to the previously mentioned membrane leakage assay also exists with 
an assay applied to the detection of the endovesiculation process.  Endovesiculation is a 
mechanistic analogue of cellular endocytosis, which was previously discussed (Section 1.2.2).  In 
these experiments (Scheme 1.4), a set of liposomes is incubated with exogenous pyranine dye 
and an endovesiculogen such as chlorpromazine or imipramine.
25, 26, 162
  Once this is completed, 
any extravesicular dye must be quenched with a membrane-impermeable quencher such as p-
xylene-bis-pyridinium bromide (DPX) at a concentration of 40 mM.  Any pyranine that is 
entrapped during endovesiculation will be inaccessible to the quencher and remain fluorescent.  
This residual fluorescence therefore serves as a measure of the extent of endovesiculation. 
Unfortunately, it has been reported that DPX can affect the fluidity of negatively charged 
membranes, alter the size of liposomes, and lower the bilayer phase transition temperatures at 
millimolar concentrations.
163
  In order to avoid these undesirable events and possible 
misinterpretation of results, a fluorescence quencher operating at a much lower concentration 
than that currently used for DPX is required for greater accuracy of endovesiculation detection 
studies. 
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1.5.6 (NBD-PE)-Sodium Dithionite Assay 
In addition to studying the aforementioned membrane events, a method for the detection 
of lipid flip within bilayers is also in high demand.  Section 1.3.3 introduced some enzymes that 
are responsible for membrane asymmetry and lipid translocation.  Lipid translocation is 
associated with apoptosis, blood clotting and several other disorders previously described 
(Section 1.3.3).  Although there are currently employed lipid flip detection assays that enable the 
monitoring of flippases, floppases and scramblases, as well as their fully synthetic and peptide 
analogues, these assays contain inherent deficiencies that need to be addressed. 
To date, three major assays are utilized for the monitoring of lipid flip in model spherical 
bilayers (liposomes).  The first method relies on the flip of transferable fluorescent 7-nitro-1,2,3-
benzoxadiazol-4-yl (NBD)-labeled lipid from the donor liposomes to the acceptor liposomes 
containing non-transferable rhodamine-labeled lipid that serves as a fluorescence quencher.
164
  
The second methodology is based on removal of the fluorescent lipid
165
 from the bilayer outer 
Scheme 1.4: Endovesiculation Detection: Liposomes are incubated with pyranine and 
endovesiculogen, followed by the fluorescence quenching with DPX; the residual 
fluorescence of entrapped dye serves as a measure of endovesiculation extent. 
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leaflet by incubation with serum albumin.
166
  The most conventional way for detection of 
flippase activity is based on the irreversible quenching of the fluorescence of NBD-labeled lipids 
in cells
167
 or liposomes 
168, 169
 with 10-60 mM sodium dithionite (Na2S2O4, Scheme 1.5).  The 
extent of lipid flip is assessed from the residual fluorescence of liposomes after the application of 
the quencher.  Due to its anionic character, dithionite exhibits low permeability to the 
hydrophobic bilayer membrane and therefore does not rapidly quench the fluorescence of the 
lipid located on the inner bilayer leaflet.  However, it quickly quenches the fluorescence of lipid 
residing on the outer leaflet.  The assay has numerous intrinsic deficiencies arising from the high 
concentration of the quencher required for the assay, the reductive nature of this reagent, and 
some permeability of the quencher to the bilayer membrane.  Thus, it has been shown recently 
that sodium dithionite diffusion through the bilayer is similar to or faster than that of 
unfacilitated lipid flip.
170
  Potentially, dithionite can reduce the disulfide cross-links found in 
some flippases.  For example, wild type human P-glycoprotein (Pgp), which is a known 
flippase,
171
 facilitates the lipid flip to a lesser extent than Pgp treated with the reducing agent due 
to the inhibitory disulfide cross-links between nucleotide binding sites.
172
  In contrast, the 
Scheme 1.5:  Representation of Lipid Flip Detection Assay:  LUVs containing 
fluorescently labeled lipids are treated with membrane-impermeable quencher.   
Alterations in the residual fluorescence of the lipids from inner bilayer leaflet serve as the 
measure of lipid flip. 
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activity of human scramblase protein is suppressed by reducing reagents due to the reduction of 
disulfide cross-links.
173
  These examples demonstrate that dithionite may affect the flipping 
activity of enzymes in a dual way and, therefore, cannot be reliably used in real time monitoring 
experiments. 
1.6 Thesis Outline 
This introduction has been devoted to presenting the importance of biomembranes, some 
of their primary functions and the necessity to monitor their activity and the action of proteins 
and enzymes within them.  Section 1.5 gave a brief introduction into some of the most current 
methods used to monitor the activities of membrane leakage and lipid flip as well as their 
inherent deficiencies.  It has been noted that fluorescence-based methodologies are a relatively 
simple, highly sensitive, versatile and inexpensive approaches for the study of biomembrane 
events.
174
  Many recent reviews outline the vast array of optical techniques that are currently 
utilized in the imaging of membranes.
10, 175, 176
  Within all of these methods, the cellular 
processes are monitored by introducing either fluorescent probe molecules (Sections 1.5.3-1.5.5) 
or previously labeled lipid probes along with the reporter molecules (Section 1.5.6).   
Unfortunately, the assays currently employed operate with high millimolar concentrations 
of small probe compounds that can interfere with membrane studies.
177,163
  Specifically, this can 
lead to undesirable interactions with membrane properties, alter the normal cellular activity, and 
interfere with the specific proteins and enzymes that are being monitored.
178-181
  Therefore, there 
is a necessity for the development of highly sensitive fluorescent sensors that can decrease the 
required concentrations of probe compounds, thereby avoiding high levels of toxicity, high cost 
of production, and competitive binding of foreign substrates.
182-184
  This dissertation specifically 
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concentrates on the need for the development of new fluorometric assays that monitor membrane 
leakage and lipid flip.  In addition, the newly developed methodology is applied toward the 
development of a step-wise content release drug delivery system.   
In Chapter 2, a newly developed membrane leakage assay is presented.
185
  Our efforts 
began with the synthesis of a new receptor, which we named cyclen 1, which is highly selective 
for anionic pyrene-based dyes and comprised of four naphthylthiourea groups tethered to a 
cyclen core via an ester linkage.  We hypothesized that this membrane impermeable receptor 
would selectively quench the fluorescence of a pH-sensitive dye pyranine at micromolar 
concentrations (Scheme 1.6A).  Visual evidence of the fluorescence quench of pyranine dye (1 
μM) in the presence of 25 μM cyclen 1 is shown in Scheme 1.6B (left vial).  This is a substantial 
improvement upon the currently utilized membrane leakage assay which requires high 
concentrations (100 mM) of pyrene dye.  This new methodology is fully compatible with the pH-
stat assay and allows for differentiation between ion transport and nonselective leakage 
B A 
1 M HPTS 
with 20 M 
Cyclen 1  
1 M HPTS with 
no Cyclen 1 
Scheme 1.6: Cyclen 1 Binding to HPTS: (A) Proposed binding mode for Cyclen 1 and 
pyranine dye.  Note: the backside unit of thiourea has been truncated for clarity.  This 
picture is speculative and for pictorial purposes only. (B) Visual evidence of pyranine 
fluorescence quench.  Both vials contain a 1 M solution of pyranine (HPTS) dye, 
however, whereas the right vial does not contain any Cyclen 1, the left vial contains 20 
M of Cyclen 1.  
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mechanisms within a singles set of experiments.  Additionally this new assay is operational at 
near-physiological pH with fast kinetics of binding.  The specificity of the cyclen 1 receptor for 
pyrene-based dyes was characterized by a series of 
1
H-NMR, microcalorimetry, UV-vis and 
fluorometry experiments. 
In Chapter 3, a novel lipid flip detection assay is presented.
186
  As an extension of our 
previous work, we decided to pursue the development of a fluorescently labeled lipid that could 
bind with the new synthetic receptor, cyclen 1.  We hypothesized that a lipid probe that 
contained a similar periphery and scaffold to that of HPTS dye would also yield high selectivity 
and rapid kinetics of binding with cyclen 1.  A new cascade-blue-labeled lipid allowed the 
development of a replacement assay for the commonly utilized NBD-dithionite methodology, 
which was operational at micromolar concentrations and did not interfere with membrane 
integrity.  Whereas fluorescence quenching of the NBD group is accomplished through its 
chemical modification in the traditional NBD-dithionite assay, the new assay relies on the non-
covalent interactions between the cascade-blue label and the receptor (Figure 1.6).  Therefore, 
the quenching can be reverted by either competitive displacement of the lipid-attached label with 
Figure 1.6:  Lipid Flip Detection Assay Components: (A) Cyclen 1 fluorescence 
quencher (B) The cascade-blue labeled lipid used to bind with cyclen 1 
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a water-soluble substrate, or by enzymatic degradation of the receptor leading to the label release 
and fluorescence quenching. We demonstrate that this new methodology is suitable for the study 
of lipid flip in both model spherical bilayer membranes and in-vitro experiments. 
In Chapter 4, the application of the new membrane leakage assay toward monitoring the 
development of a step-wise content release drug delivery system is discussed.  Within these 
studies a series of new pH-sensitive lipids were synthesized to be utilized in liposomes that 
contain varying amounts of NaCl in their internal compartments.  After addition of an HCl co-
transporter and an exogenous solution of NaCl, each set of liposomes begins to undergo internal 
acidification.  This is due to the uptake of HCl by the co-transporter, which is responding 
proportionally to the Cl
-
 gradient across the liposomes that contain differing amounts of internal 
NaCl.   Over time, the internal acidification of liposomes leads to the hydrolysis of the pH-
sensitive lipids and subsequent contents release at the desired time (Figure 1.7).  This stepwise 
content release system could potentially be applied to a drug release system, where stages of 
time course 
30 mM  
NaCl 
pH 5.6 
pH 6.5 
 pH 7.2 
 pH 6.5 
  pH 7.2   pH 7.2 
HCl transporter  
100 mM  
NaCl 
 0 mM 
 NaCl 
Figure 1.7:  Stepwise Release of Liposome Contents Triggered by a 
Single Application of HCl Co-Transporter 
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contents release are separated by periods of low activity.   The conclusions from this preliminary 
work as well as future work will be presented in this chapter. 
 1.7 Conclusions 
The strict regulation of cellular processes is vital for cell survival, and deficiencies within 
these cellular pathways can lead to various channelopathies.  Therefore, methodologies for 
monitoring specific processes such as exocytosis, endocytosis and apoptosis are in high demand.  
Current methodologies for monitoring biomembrane activity range from nuclear magnetic 
resonance, patch clamp and a wide range of fluorometric assays.  Unfortunately, many of these 
widely accepted protocols contain inherent deficiencies that necessitate improved methodologies. 
Therefore, this work focuses on the development of cyclen-thiourea based receptors 
which have a high affinity for fluorescent dyes.  These receptor-fluorescent dye pairs provide a 
non-invasive, physiologically compatible, accurate methodology suitable for the study of 
membrane leakage and lipid flip events, which are both critical processes in cellular membrane 
activity.  The approaches described within this work address intrinsic deficiencies that have been 
observed in widely accepted protocols.  Those protocols show undesirable interactions with the 
bilayer membranes due to the small nature of the molecular probe compounds utilized, which 
tend to have lower binding affinities requiring higher concentrations.  A macromolecular 
approach that can increase the specificity of binding, thereby lowering concentrations of the 
probe compounds used in the fluorometric detection of biomembrane events, is in high demand 
by the biochemical community and a target for developmental pharmaceuticals.  These receptor-
dye complexes provide useful insight into biomembrane processes and allow the development of 
a newly-designed drug delivery system. 
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Chapter 2 
Receptor for Anionic Pyrene Derivatives Provides the Basis  
for New Biomembrane Assays 
 
This chapter was reproduced with permission from J. Amer. Chem. Soc.  2005, 127, 14704-
14713 from the American Chemical Society. 
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2.1 Abstract 
 This study describes a new receptor cyclen 1 capable of strong selective binding of 
pyrene-based anionic dyes under near-physiological conditions.  This receptor comprises four 
naphthylthiourea groups tethered to a cyclen core via an ester linkage.  The complexation 
behavior of cyclen 1 receptor is characterized by a series of 
1
H NMR, microcalorimetry, UV-vis, 
and fluorometry experiments.  The relevance of structural features of this receptor to its 
recognition function is assessed using control compounds that lack some of the groups found in 
cyclen 1.  The specificity of cyclen 1 toward pyrene-based dyes is assessed through experiments 
using dyes with different molecular organization.  The most important finding was the ability of 
cyclen 1 to bind efficiently to a pH-sensitive pyranine dye, a dye that is commonly used in 
various biomembrane assays.  The high affinity of cyclen 1 to pyranine, its impermeability to the 
lipid bilayer membrane, fast kinetics of binding, and ability to quench the pyranine’s 
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fluorescence were used as a basis for a new membrane leakage assay.  This membrane leakage 
assay is fully compatible with the commonly applied pH-stat transport assay, and therefore it 
allows for differentiation of the ion transport and nonselective leakage mechanisms within a 
single set of experiments.  The ability of cyclen 1 to quench the fluorescence of pyranine also 
finds limited applicability to the detection of endovesiculation. 
2.2 Introduction  
Synthetic ionophores
187
 have shown promise as a basis for new antibiotics,
188-191
 
therapeutics or genetic diseases,
128, 192-194
 sensors,
195-197
 and enzyme mimetics.
198-200
  As a result, 
there is a growing need for the development of assays to rapidly assess the activity of such 
compounds under near-physiological conditions.  Along with 
23
Na NMR
201-205
 and planar bilayer 
voltage-clamp
206-209
 (PBVC) experiments, the liposome-based pH-stat fluorometric assay is an 
assay routinely used for identification of physiologically relevant ionophores (Chart 2.1A).
155
  
In this assay, a controlled amount of base and potential ionophore is added to a suspension of 
liposomes containing a pH-sensitive dye, 8-hydroxypyrene-1,3,6-trisulfonate (HPTS, pyranine), 
or sometimes fluorescein.
148-152
  Pyranine is preferred due to the pKa value complying with the 
physiological pH range and two distinct excitation maxima found for its protonated and 
deprotonated forms.  The ratiometric monitoring of pH using these two excitation maxima makes 
the observed response independent from pyranine concentration.  The resulting pH gradient 
across the bilayer membrane causes the efflux of hydronium ions and builds up an electrostatic 
potential.  This potential can be compensated by the efflux of anions or influx of cations.  If the 
compound of interest mediates such ion transport, the efflux of hydronium ions continues 
altering the intravesicular pH and the fluorescence of the reporter dye.  The kinetic trace obtained 
from the dye response thus reflects the ionophoretic activity of the studied compound.  While 
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being rapid and reliable, the pH-stat assay provides little information on the mechanism of ion 
transport.
1
  PBVC experiments provide mechanistic information in high detail;
1
 however, these 
methods often lack reproducibility and require specific skills and an extensive time 
investment.
156, 157, 207
  The results of pH-stat and PBVC experiments do not necessarily correlate 
due to the difference in membrane models and experimental conditions.
156-158
  
 A membrane leakage assay addresses some mechanistic aspects by distinguishing 
selective ion transport from nonselective leakage through oversized pores (Chart 2.1B).
159, 160
  
Chart 2.1: (A) pH-Stat Experiment;
a
 (B) Membrane Leakage Assay;
b
 (C) Endovesiculation 
Detection 
a
The fluorescence of the pH-sensor pyranine in liposomes is monitored as a 
function of time; the H
+
 release is a result of exogenous application of the base and 
ionophore. 
b
LUVs containing calcein are probed with the ionophore. In the case of large 
pore formation, the self-quenching dye is released and restores the emission. 
c
Liposomes are 
incubated with pyranine and endovesiculogen, followed by the fluorescence quenching with 
DPX; the residual fluorescence of entrapped dye serves as a measure of endovesiculation 
extent. 
 32 
 
This assay utilizes the ability of calcein or carboxyfluorescein (CF) dyes to self-quench their 
fluorescence emission at ~100 mM concentration.  In a typical experiment, a set of large 
unilamellar vesicles (LUVs) containing the concentrated dye is challenged with the compound of 
interest.  In the case of selective ion transport, little change in fluorescence is observed, whereas 
the larger pore formation results in the dye release, its subsequent dilution, and emission 
increase.  However, whereas the pH-stat assay is based on LUVs containing the dye at low 
concentration (100 μM), the high concentration of the dye in leakage assays (100 mM) could 
alter the membrane properties, change the buffer capacity, and interact with the ionophore.  For 
optimal compatibility and reliability, the same LUVs should be utilized in both pH-stat and 
membrane leakage assays. 
 As one of the reviewers pointed out, a similar problem exists with an assay applied to the 
detection of the endovesiculation process, a mechanistic analogue of cellular endocytosis.
25, 26
  
Endovesiculation is detected through the incubation of liposomes with exogenous pyranine and 
endovesiculogen, followed by the quench of extravesicular dye with the membrane-impermeable 
dynamic quencher p-xylene-bis-pyridinium bromide (DPX) at 40 mM concentration (Chart 
2.1C).  The portion of the dye entrapped during endovesiculation is inaccessible to the quencher 
and remains fluorescent.  This residual fluorescence serves as a measure of the endovesiculation 
extent.  It has been reported that DPX affects the fluidity of negatively charged membranes, 
alters the size of LUVs, and lowers the bilayer phase transition temperatures at millimolar 
concentrations.
163
  To avoid all these artifact events and misinterpretations of results, a 
fluorescence quencher operating at much lower concentration than currently used DPX is 
required for endovesiculation detection. 
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2.3 Experimental Section 
 2.3.1 General   
The 
1
H NMR spectra were recorded on a Varian AS400 instrument operating at 400.130 
MHz or a Varian Mercury instrument operating at 299.865 MHz.  Chemical shifts are reported in 
ppm relative to the residual protonated solvent peak.  The 
13
C NMR spectra were recorded on the 
same instruments at 100.613 and 75.408 MHz, respectively, and chemical shift values are 
reported in ppm relative to the solvent peak.  Both 
1
H and 
13
C spectra were taken in the same 
solvent and on the same instrument for each sample.  The low-resolution mass spectra were 
recorded on a Micromass Q-TOF 2 instrument (Manchester, U.K.) using the electrospray 
technique (positive mode).  The samples were introduced into a mass spectrometer using a flow 
rate of 10 μL/min, the needle voltage was set at 3500 V with ion source at 110°C, and the cone 
voltage at 35 V.  The high-resolution mass spectra were recorded on a LCMS-IT-TOF 
(Shimadzu Corporation, Columbia MD) instrument using the electrospray technique (positive 
mode).  All spectrophotometric experiments were carried out on a Fluoromax 3 (Jobin-
Yvon/Horriba) spectrophotometer.  The dynamic light-scattering analysis of the liposome 
suspensions was carried out on the Malvern instrument (Malvern Zetasizer Nano Series, Malvern 
Instruments).  Microcalorimetric titrations were performed using a VP-ITC microcalorimeter 
(MicroCal, LLC, Northampton MA), and the ORIGIN-7 software was used to calculate the 
binding constants and the enthalpy changes.  The pH of solutions was monitored with a Corning 
350 pH/ion analyzer, using a Ag/AgCl pH-sensitive electrode (Accumet).  Chromatography was 
performed using 60-200-mesh silica purchased from Baker and 40-120 μm Sephadex G-75 
purchased from Aldrich.  Thin-layer chromatography was performed on Kieselgel 60 F254 and 
Uniplate Silica Gel GF silica-coated glass plates and visualized by UV and I2.  High-pressure 
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extrusion was performed on the Avanti mini-extruder with a 0.1 μm polycarbonate membrane.  
All chemicals, solvents, and dyes were purchased from Aldrich, Sigma, Fluka, and Invitrogen.  
Egg yolk phosphatidylcholine was purchased from Avanti Polar Lipids.  
 2.3.2 Synthesis   
The synthetic scheme for compounds 1-3 is shown in Scheme S1 of Appendix A, and the 
synthetic procedure for compound 4 is shown in Scheme S2 of Appendix A.  
Bromoacetic Acid 2-t-Butoxycarbonylaminoethyl Ester 1a.  tert-Butyl-N-(2-hydroxy ethyl) 
carbamate (4.5 g, 28 mmol) was dissolved in dichloromethane (30 mL), and triethylamine (3.9 
mL, 28 mmol) was added.  The mixture was stirred for 10 min at room temperature, and 
bromoacetyl bromide (3.15 mL, 36 mmol) was added dropwise within 5 min.  The reaction 
mixture was stirred for 5 h at room temperature, the solvent was removed under reduced 
pressure, and the crude solid was purified by column chromatography (silica gel, CH2Cl2/EtOAc 
4:6) to give 7.0 g of product 1a (25 mmol, 90%).  
1
H NMR (300 MHz, DMSO-d6, δ): 6.94 (t, 1 
H, J = 5.7, 5.4 Hz), 4.11 (s, 2 H), 4.06 (t, 2 H, J = 5.7, 5.4 Hz), 3.15 (td, 2 H, J = 5.7, 5.7 Hz), 
1.35 (s, 9 H); 
13
C NMR (DMSO-d6, δ): 167.7, 156.3, 78.5, 65.1, 39.3, 28.8, 27.9. MS (ESI) 
([M+Na]
 +
): 304.01, calcd for C9H16BrNO4Na 304.02.  
[4,7,10-Tris-(2-tert-butoxycarbonylamino-ethoxycarbonylmethyl)-1,4,7,10-tetraaza-
cyclododec-1-yl]-acetic Acid 2-tert-butoxycarbonylamino-ethyl Ester (cyclen NH-Boc) 3.  
Cyclen (0.4 g, 2.3 mmol), sodium carbonate (2.19 g, 20.7 mmol), and bromoacetic acid 2-tert-
butoxycarbonylamino ethyl ester (3.8 g, 13.8 mmol) were suspended in 20 mL of acetonitrile.  
The reaction mixture was stirred for 72 h at room temperature, and the solvent was removed 
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under reduced pressure.  The solid residue was purified by column chromatography (silica gel, 
CH3OH/CHCl3 5:95) to afford 1.28 g of cyclen NH-Boc 3 (1.3 mmol, 56%).  
1
H NMR (400 
MHz, DMSO-d6, δ): 6.89 (t, 4 H, J = 5.6, 6.0 Hz), 4.03 (br s, 8 H), 3.15 (br s, 8 H), 2.95-2.64 (br 
m, 16 H), 1.34 (s, 36 H); 
13
C NMR (DMSO-d6, δ): 174.0, 156.4, 78.5, 64.4, 55.4, 50.4, 28.8. MS 
(ESI, high-resolution) [M+H]
+
, rel intensity 100.00: 977.5734, calcd for C44H81BrN8O16 
977.5765; [M+Na]
+
, rel intensity 20.90: 999.5611, calcd for C44H80BrN8O16Na 999.5585.  
(4,7,10-Tris-[2-(3-naphthalen-1-yl-thioureido)-ethoxycarbonylmethyl]-1,4,7,10-tetraaza-
cyclododec-1-yl)-acetic Acid 2-(3-naphthalen-1-yl-thioureido)-ethyl Ester 1.  Cyclen NH-
Boc 3 (1.0 g, 1 mmol) was dissolved in 10 mL of CH2Cl2, and trifluoroacetic acid (8 mL of 50% 
v/v solution in CH2Cl2) was added dropwise.  The reaction mixture was stirred for 6 h at room 
temperature, and the solvent and excess of trifluoroacetic acid were removed under reduced 
pressure to afford crude deprotected cyclen 1b tertrafluoroacetate (0.623 g, 0.603 mmol).  
Deprotected cyclen 1b was reacted without further purification.  The total amount obtained was 
dissolved in 15 mL of isopropyl alcohol, and 1-naphthyl isothiocyanate (1.5 g, 8 mmol) was 
added.  After 15 min, triethylamine was added slowly to bring the pH to 9.  The reaction mixture 
was stirred for 12 h at room temperature and then evaporated to dryness under reduced pressure.  
The crude solid was purified by column chromatography (silica gel, CH3OH/CHCl3 5:95) to 
afford 0.26 g of pure cyclen 1 (0.2 mmol, 20% in two steps).  
1
H NMR (400 MHz, DMSO-d6, δ): 
9.64 (s, 4 H), 7.92-7.81 (br m, 12 H), 7.51-7.41 (br m, 20 H), 4.17 (br s, 8 H), 3.72 (br s, 8 H), 
2.92 (br s, 8 H), 2.63-2.63 (br m, 16 H); 
13
C NMR (DMSO-d6, δ): 182.8, 174.0, 134.6, 130.4, 
128.8, 128.3, 127.5, 126.9, 126.6, 126.4, 125.8, 123.5, 63.6, 55.4, 50.8, 43.4. MS (ESI, high-
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resolution) [M+H]
+
, rel intensity 100.00: 1317.4850, calcd for C68H77N12O8: 1317.4865; 
[M+Na]
+
, rel intensity 36.12: 1339.4681, calcd for C68H76N12O8Na 1339.4684.  
(4,7,10-Tris-[2-(3-phenyl-thioureido)-ethoxycarbonylmethyl]-1,4,7,10-tetraaza-cyclododec-
1-yl)-acetic Acid 2-(3-phenyl-thioureido)-ethyl Ester 2.  This compound was synthesized from 
cyclen NH-Boc 3 (0.6 g, 0.61 mmol) and phenyl isothiocyanate (0.6 mL, 5 mmol) according to 
the procedure described for the synthesis of cyclen 1.  The isolated yield of cyclen 2 was 0.12 
mmol, 23%.  
1
H NMR (400 MHz, DMSO-d6, δ): 9.62 (br s, 4 H), 7.91 (br s, 4 H), 7.34-7.26 (br 
m, 16 H), 7.10-7.06 (t, 4 H), 4.22 (br s, 8 H), 3.73 (br s, 8 H), 2.94 (br s, 8 H), 2.67-2.63 (br m, 
16 H); 
13
C NMR (DMSO-d6, δ): 181.4, 174.0, 139.7, 129.3, 124.9, 123.7, 63.8, 55.5, 50.8, 43.1. 
MS (ESI) ([M+Na]
+
):1139.3, calcd for C52H68N12O8Na 1139.40. 
1-(2-Hydroxy-ethyl)-3-naphthalen-1-yl-thiourea 4a.  This compound was synthesized 
according to the literature.
210
  2-Ethanolamine (0.18 mL, 2.7 mmol) was dissolved in 6.5 mL of 
EtOAc, and 1-naphthyl isothiocyanate (0.502 g, 2.7 mmol) was added.  The reaction mixture was 
stirred for 20 min at room temperature.  The white precipitate that was formed was washed with 
ethyl acetate, filtered, and purified by column chromatography (silica gel, EtOAc/CH2Cl2 9:1).  
Final recrystallization of the product from toluene gave 0.538 g of 4a (2.19 mmol, 81%).  
1
H 
NMR (DMSO-d6, 25°C, δ): 9.65 (s, 1 H), 7.95-7.91 (m, 1 H), 7.88-7.80 (m, 2 H), 7.56-7.46 (m, 
5 H), 4.71 (s, 1 H), 3.52-3.50 (br d, 4 H, J = 6 Hz); 
13
C NMR (DMSO-d6, δ): 182.6, 135.1, 134.6, 
130.4, 128.8, 127.1, 126.8, 126.3, 125.6, 123.4, 59.9, 47.3. MS (ESI) ([M+H]
+
): 247.8, calcd for 
C13H14N2OS 246.08.  
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Dimethyaminoacetic Acid 2-(3-naphthalen-1-yl-thioureido)-ethyl Ester 4.  To a solution of 
N,N-dimethyl glycine (103 mg, 1 mmol) in 10 mL of CH2Cl2, 1,1'-carbonyldiimidazole (162 mg, 
1 mmol) was added.  The reaction mixture was stirred for 3
1
/2 h at room temperature, then 1-(2- 
hydroxy-ethyl)-3-naphthyl-thiourea (198 mg, 0.8 mmol) was added, and the reaction was stirred 
for another 12 h at room temperature.  The solvent was evaporated under reduced pressure, and 
the residual solid was partitioned in chloroform/water.  The organic layer was separated, and the 
solvent was removed under reduced pressure.  The crude product was purified by column 
chromatography (silica gel, CH3OH/EtOAc 3:97) to give pure monomer 4 as a white solid (67 
mg, 0.202 mmol, 25%).  
1
H NMR (300 MHz, DMSO-d6, δ): 9.74 (s, 1 H), 7.96-7.92 (m, 1 H), 
7.87-7.81(m, 2 H), 7.57-7.41 (m, 5 H), 4.14 (t, 2 H, J = 5.6 Hz), 3.67 (td, 2 H, J = 5.5, 5.4 Hz), 
3.09 (s, 2 H), 2.20 (s, 6 H); 
13
C NMR (DMSO-d6, δ): 182.7, 170.8, 134.7, 130.5, 128.8, 127.6, 
126.9, 126.9, 126.4, 125.9, 123.5, 62.6, 59.9, 45.2, 43.6. MS (ESI, high-resolution) ([M+H]
+
): 
332.1408, calcd for C17H22N3O2S 332.1427.  
 2.3.3 Liposome Preparation for pH-Stat and Membrane Leakage Assay 
Egg yolk L-α-phosphatidylcholine (EYPC ethanol solution, 60 μL, 79 μmol) was 
dissolved in a CHCl3/MeOH mixture, the solution was evaporated under reduced pressure, and 
the resulting thin film was dried under high vacuum for 2 h.  The lipid film was hydrated for 40 
min in 1.2 mL of sodium phosphate buffer (10 mM sodium phosphate, pH = 6.4, 100 mM NaCl,) 
containing 100 μM pyranine.  During hydration, the suspension was submitted to three freeze-
thaw cycles (dry ice/acetone, water at room temperature).  The resulting suspension of large 
multilamellar vesicles (1 mL) was submitted to high-pressure extrusion at room temperature.  As 
judged by the dynamic light scattering analysis, 21 extrusions through a 0.1-μm polycarbonate 
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membrane afforded a suspension of LUVs with an average diameter of 130 nm.  The LUV 
suspension was separated from the extravesicular dye by size-exclusion chromatography (SEC) 
(stationary phase: Sephadex G-75, mobile phase: pyranine-free sodium phosphate buffer of the 
same composition) and diluted with the same sodium phosphate buffer to give a stock solution 
with a lipid concentration of 11 mM (assuming 100% of lipid was incorporated into liposomes).  
 2.3.4 Liposome Preparation for Endovesiculation Detection Assay 
LUVs for the endovesiculation detection were prepared analogously to those for the 
membrane leakage assay, except that the 100 mM HEPES/100 mM NaCl buffer (pH 7.1) 
containing pyranine at 0-90 μM concentrations was used instead of PBS for lipid hydration and 
the extrusion was carried out using 1 μm polycarbonate membrane. The dynamic light scattering 
(DLS) analysis of the final LUV suspension revealed a 600 nm average diameter of liposomes.  
 2.3.5 pH-Stat Transport Assays 
In a typical experiment, 100 μL of pyranine-loaded LUVs (stock solution) was suspended 
in 1.9 mL of the symmetric pyranine-free buffer and placed into a thermostated 
spectrophotometric cell.  The suspension of liposomes was gently stirred throughout the entire 
course of the experiment.  The emission of pyranine at 510 nm was monitored with concurrent 
excitation at 405 and 460 nm.  The emission and excitation slits of the spectrophotometer were 
set at 5 nm, time increments were set at 2 s, and the integration time was set at 0.5 s.  The 
temperature of the spectrophotometric cell was set at 25°C.  During the experiment, 20 μL of a 
0-100 μM DMSO solution of gramicidin or 0-500 μM aqueous solution of melittin was added 
through the injection port, followed by injection of 21 μL of 0.5 M aqueous NaOH.  Addition of 
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NaOH resulted in a pH increase of approximately 1 pH unit in the extravesicular buffer, as 
established by separate pH monitoring.  Maximum possible changes in dye emission were 
obtained at the end of each experiment by lysis of the liposomes with detergent (40 μL of 25% 
aqueous Triton X-100).  The final transport trace was obtained as a ratio of the emission 
intensities monitored at 460 and 405 nm and was normalized to 100% of transport.  
 2.3.6 Membrane Leakage Assays 
The stock solution of the same LUVs as used in the pH-stat assays (100 μL) was 
suspended in 1.9 mL of the symmetric pyranine-free buffer and placed into a thermostated 
spectrophotometric cell.  The instrumental settings were the same as in the pH-stat transport 
experiments.  The suspension of liposomes was gently stirred throughout the course of the 
experiment.  The emission of pyranine at 510 nm was monitored with excitation wavelength at 
405 nm.  During the experiment, 20 μL of a 0-1 mM solution of cyclen 1 in DMSO was injected 
into the suspension of LUVs, followed by the injection of 20 μL of the same solution of 
ionophore (gramicidin or melittin) as used in the pH-stat assays.  The incubation time between 
injections of cyclen 1 and peptide was 40 s.  When necessary, the sequence of injections was 
inverted, and the incubation time for the suspension of LUVs with peptide was increased up to 
240 s.  Maximal possible changes in the dye emission were obtained at the end of each 
experiment by lysis of LUVs with detergent (40 μL of 25% aqueous Triton X-100).  The traces 
were normalized to 100% of the emission change of pyranine.  
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 2.3.7 Microcalorimetric Titrations 
The ITC titrations were carried out at 25°C using 1.423 mL of a methanolic solution of 
titrated compound in the sample cell and the same amount of pure methanol in the reference cell.  
In each experiment, a total of 40 injections of constant volume (7 μL) of the titrant solution was 
made into the sample cell.  The injections were separated by a lag time of 300 s.  The heat 
change associated with the dilution of titrant in the injection series was assessed from 
independent experiments, where the titrant solution of the same concentration was injected into 
the pure solvent.  The integrated data were corrected by the amount of heat evolved from the 
dilution of titrant, and the mole ratios were corrected by the dilution of components associated 
with the volume change during an experiment.  
 2.3.8 Fluorometric Titration of Pyranine with Cyclen 1 
The fluorometric titration of pyranine with cyclen 1 shown in Figure S4 in Appendix A.  
In a typical experiment, an aqueous solution (2 mL) containing 50 nM pyranine, 100 mM NaCl, 
and 10 mM NaxH3-xPO4 (x = 1,2; pH 6.4) was placed into a thermostated spectrophotometric cell 
set at 25°C.  The solution was gently stirred during the experiment.  Prior to the 
spectrophotometric recording, 20 μL of 0-500 μM solution of cyclen 1 in DMSO was added.  
The emission spectra were recorded with the excitation wavelength 405 nm.  The recording was 
performed immediately after the addition of cyclen 1 and repeated after 30 min.  Most of the 
fluorescence loss occurred instantly upon the addition of cyclen 1.  No further change of 
emission was observed at times longer than 30 min.  For the accurate assessment of the binding 
constant, the emission maxima at 510 nm recorded after a 30-min delay time were used for the 
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binding isotherm fitting.  Binding constant and the maximum emission loss with the confidence 
interval values were computed using the homemade nonlinear regression curve-fitting program.  
The 1:1 binding model was used.  
 2.3.9 Fluorometric Experiments with Control Compounds and Dyes 
The titration of pyranine solutions with the control compounds was performed 
analogously to that with cyclen 1, except that the concentrations of cyclen NH-Boc 3 and 
monomer 4 in these experiments were varied in the range of 0-100 μM and the concentration of 
cyclen 2 was varied in the range of 0-20 μM.  The titration of PTA, APTS, ANTS, calcein, 5-CF, 
6-CF, and safranin O with cyclen 1 was identical to that of pyranine.  The control dyes were kept 
at 50 nM concentration, whereas the concentration of cyclen 1 in the titration series was varied in 
the range of 0-20 μM.  Table S1 in Appendix A summarizes the instrumental settings for the 
fluorometric monitoring of the dyes.  No detectable change in the emission of calcein and 5-CF 
was observed, whereas 9% fluorescence loss was observed for 6-CF in the presence of 20 μM 
cyclen 1.  
 2.3.10 UV-Vis Titrations 
The spectra of the dyes were recorded for the solutions in 1% of DMSO in PBS with 1% 
DMSO in PBS used as blank.  For the spectra of the dyes in the presence of cyclen 1, the 
solution of cyclen 1 in 1% of DMSO in PBS was used as a blank.  
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2.4 Results and Discussion 
 2.4.1 Design of the Receptor  
We reasoned that a compound capable of selective binding of pyranine (Chart 2.2A) at 
micromolar concentrations, impermeable to the bilayer membrane, and capable of quenching of 
pyranine fluorescence would provide the basis for improved assays that do not rely on a high 
concentration of pyranine quencher.  The structure of pyranine comprises a planar pyrene core 
and four peripheral anionic groups.  It has been reported that cyclen tetraesters bind 
physiologically abundant Na
+
, forcing all four ester termini to come into close proximity.
211, 212
  
We speculated that if two of these termini would hydrogen-bond to pyranine sulfonates and 
phenolate and the two other termini would π–stack with pyranine’s aromatic core, we would 
achieve a receptor for this dye.  Additional stabilization of the complex is envisioned through the 
electrostatic interactions of the protonated cyclen scaffold with anionic suflonates and the 
phenolate of pyranine.  Cyclen 1 satisfied these requirements and was synthesized via a four-step 
procedure (Appendix 1).  The schematic representation of the envisioned binding mode cyclen 1 
and pyranine is shown on Chart 2.2B. 
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 2.4.2 Pyranine-Cyclen 1 Complex Characterization 
The first indication of interaction between cyclen 1and pyranine dye was obtained from 
the extraction experiments.  When a chloroform-d (CDCl3) solution of cyclen 1 was treated with 
an aqueous solution of pyranine, formation of precipitate was observed.  Regardless of the 
pyranine and cyclen 1 mole ratios, the minor component was always almost completely removed 
from the solution phase upon extraction.  The precipitate formed was soluble in dimethyl 
sulfoxide-d6 (DMSO), and the 
1
H NMR spectrum of this DMSO solution has shown signals 
corresponding to pyranine and cyclen 1.  The chemical shifts of pyranine and cyclen 1 signals in 
DMSO were identical to those recorded for pyranine and cyclen 1 alone, suggesting that the 
complex was destroyed by this solvent.  The integral ratios for signals of two compounds were 
independent of their mole ratios in the extraction series and corresponded to 1:1 complex 
stoichiometry. 
 To gain more information on the thermodynamics of the complexation process, we 
performed a series of isothermal titration calorimetry (ITC) experiments.  The ITC experiments 
require substantial solubility of interacting components in the common solvent, although 
formation of a precipitate upon interaction is acceptable.
213-215
  Cyclen 1 has a very limited 
solubility in water, therefore methanolic solutions were used instead.  Both pyranine and cyclen 
1 have a solubility of at least 15 mM in methanol which was suitable for ITC titrations.  As with 
the extraction experiments, the addition of a methanolic solution of pyranine to cyclen 1 resulted 
in an extensive precipitate formation. 
 The formation of two distinct types of complexes was observed when a 10 mM solution 
of cyclen 1 was titrated into a 0.25 mM solution of pyranine in an ITC experiment (Figure 2.1).  
The assessed thermodynamic data for these complexes are summarized in Table 2.1.   
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 Table 2.1:  Thermodynamic Parameters Assessed for the Complexation of Pyranine with Cyclen 
1 in Methanol
a
 
Na Ka(M
-1) ΔG (kcal/mol) ΔH (kcal/mol) TΔS (kcal/mol) 
     
1.28 ± 0.014 (3.16 ± 0.75) × 106 −8.87 ± 0.17 −0.41 ± 0.05 8.47 
3.57 ± 0.050 (1.46 ± 0.12) × 104 −5.68 ± 0.05 −3.87 ± 0.08 1.81 
a 
Number of binding sites for the individual complexation step obtained from the data fit to two sets of sites binding 
model 
Figure 2.1: Microcalorimetric Characterization of Interactions of Cyclen 1 with Pyranine and 
Calcein in Methanol: (A) Raw data for the titration of a 0.25 mM solution of pyranine with a 10 
mM solution of cyclen 1. (B) Integrated data from (A), corrected by the heat of cyclen 1 
dilution, normalized to moles of injectant and plotted as a function of cyclen 1/pyranine ratios 
(solid squares). A continuous line represents the data fit in two sets of sites binding model. (C) 
Raw data for the titration of a 0.25 mM solution of calcein with a 10 mM solution of cyclen 1. 
Note the difference in vertical scales for plots (A) and (C). (D) Integrated data from (C), 
corrected by the heat of cyclen 1 dilution, normalized to moles of injectant and plotted as a 
function of cyclen 1/calcein ratios. 
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The first complex shows 1:1 stoichiometry, whereas the second complex corresponds to 
the overall 1:4 pyranine/cyclen 1 stoichiometry.  These two complexes have different affinities 
and are driven by different thermodynamic forces.  The originally formed 1:1 complex is 2 
orders of magnitude stronger than the subsequently formed 1:4 complex.  Whereas the formation 
of the 1:4 complex is an enthalpically driven process, the 1:1 complex formation is almost 
entirely an entropically driven process.  The entropically driven 1:1 binding is consistent with the 
solvophobic effect most likely accompanying π-π rather than hydrogen-bonding or electrostatic 
interactions.
216, 217
  A much weaker 1:4 complex formation is a mostly enthalpically driven 
process accompanied by a smaller positive entropy change.  This second complexation step is 
probably due to the electrostatic and/or hydrogen-bonding interactions of cyclen 1 molecules 
with the initially formed 1:1 complex.  Although the solvophobic effect plays a role in the 1:4 
complex formation as well, the diminished entropy change likely stems from the decrease in the 
degrees of freedom for the large aggregate formed from several molecules.  Noteworthy, no 
additional inflection points between 1:1 and 1:4 pyranine/cyclen 1 ratios were observed in the 
ITC plot, suggesting that the second binding process proceeds via a concerted cooperative 
mechanism. 
 
1
H NMR analysis of the precipitate formed upon addition of an equimolar amount of 
cyclen 1 to pyranine in methanol revealed that these two compounds produced a 1:1.5 mixture.  
This ratio can be explained by the concurrent formation of a 1:1 complex (83%) and a 1:4 
complex (17%).  Clearly, the complexation of pyranine with cyclen 1 is a solvent-dependent 
process: whereas 1:1 complexes were formed from both aqueous and methanolic solutions, the 
enthalpically favored 1:4 complex was observed only for methanol, consistent with the fact that 
electrostatic and hydrogen-bonding interactions are weakened in water compared to less-polar 
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methanol.
218-220
  The fact that the complex between pyranine and cyclen 1 apparently does not 
form in a polar but not self-associated solvent such as DMSO
221-223
 also supports the solvophobic 
effect as a primary driving force for the complex formation.  No apparent complex formation 
between cyclen 1 and pyranine was observed in acetonitrile as well.  
 2.4.3 Evaluation of Cyclen 1 Affinity and Specificity to Pyranine under Near-
Physiological Conditions 
To be useful for kinetic biomembrane fluorometric assays, the pyranine receptor must (a) 
have high affinity to the dye under physiological conditions; (b) be impermeable to the 
membrane bilayer; (c) have fast kinetics of interaction with the dye; and (d) alter the 
fluorescence of the dye significantly. 
 The solubility of cyclen 1 in aqueous medium is very limited, and even if the binding to 
pyranine is strong, the capacity of cyclen 1 for binding with increasing amounts of the dye is 
limited by its concentration in the solution.  We detected the solubility limit for cyclen 1 in a 
phosphate saline buffer (PBS, 100 mM NaCl, 10 mM Pi, pH=6.4) through a series of UV-vis 
experiments where the absorbance of cyclen 1 solutions was plotted as a function of its 
concentration (Figure S6, Appendix A).  The saturation of absorbance was reached between 20 
and 30 μM of cyclen 1 concentration.  This concentration was ascribed to the limiting solubility 
of cyclen 1 in PBS.  At concentrations of 40 μM and above, precipitation was visually observed. 
 Titration of pyranine with cyclen 1 in PBS demonstrated an extensive loss of the dye 
fluorescence (Figure S4, Appendix A).  This loss was insensitive to the presence of Cl
-
 and, 
surprisingly, to Pi.
224-226
  The assessment of the binding constant gave an apparent value of (2.6 ± 
0.3) x 10
6
 M
-1
 (Table 2.2), meaning that low micromolar concentrations of cyclen 1 are 
sufficient to quench pyranine emission.  Interestingly, the Ka value assessed for the pyranine-
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cyclen 1 complex in PBS from fluorometric titrations was very close to the Ka value determined 
by ITC for the 1:1 complexation step in methanol.  Although receptors for pyranine of lower
227
 
or comparable affinity are known,
199, 228
 to the best of our knowledge no fluorescence quenchers 
for pyranine, active at such low concentration, have been reported to date.  The affinity of cyclen 
1 to pyranine in aqueous medium compares favorably to that of the other artificial receptors for 
anionic substrates.
228-231
  Importantly, the application of cyclen 1 to egg yolk 
phosphatidylcholine (EYPC) LUVs loaded with 100 μM PBS solution of pyranine did not result 
in a significant loss of pyranine fluorescence, showing that cyclen 1 is impermeable to the 
bilayer membrane. 
 
Table 2.2:  Binding Constants and Maximal Fluorescence Loss Assessed for the Complexes of 
Pyrene-Based Dyes and Cyclen 1 from Fluorometric Titration in PBS
a
 
 HPTS PTA APTS HPTS-2b 
     
Ka (M
-1
) (2.6 ± 0.3) × 106 (2.1 ± 0.5) × 106 (7.7 ± 1.0) × 105 (9.2 ± 1.3) × 105 
 
I
max
rel (%) 90.9 ± 1.6 103 ± 4.7 99.3 ± 2.8 96 ± 3.0 
 
a 
 A 1:1 binding mode was assumed; 
b Binding parameters assessed for pyranine−cyclen 2 complex. 
 
 The binding of pyranine to cyclen 1 in methanol and in the water/chloroform extraction 
experiments at high (millimolar) concentrations was always associated with extensive complex 
precipitation.  It was not clear whether the same precipitation is a leading cause of the 
fluorescence disappearance at nanomolar concentrations of pyranine.  To determine the reason 
for this fluorescence loss, a parallel series of UV-vis and fluorometric experiments were 
performed.  A PBS solution containing 20 μM of pyranine and 20 μM cyclen 1 showed a 
decrease in both pyranine absorbance at λmax = 406 nm and pyranine emission at 510 nm with 
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excitation at 405 or 460 nm (Figure S5, Appendix A).  This result was inconclusive, as the loss 
of absorbance could be due to the complex precipitation or hypochromic shift induced by cyclen 
1.  However, when the concentration of pyranine and cyclen 1 were reduced to 2.67 and 10 μM 
respectively, the fluorometric experiment still showed a loss of pyranine fluorescence, whereas 
the UV-vis experiment showed an increase in pyranine absorbance accompanied by a modest 
bathochromic shift (Figure 2.2).  This hyperchromic shift cannot be due to the complex 
precipitation, and therefore it reflects the binding of cyclen 1 and pyranine in solution.  We 
concluded that the solubility product, Ksp, for the pyranine complex in PBS is higher than 2.67 x 
10
-11
 and is lower than 4 x 10
-10
.  The emission quenching observed in the fluorescence titration 
series with pyranine at 50 nM and cyclen 1 at up to 10 μM concentrations therefore corresponds 
to a concentration product of up to 5 x 10
-13
, which is below the solubility product for this 
complex.  We concluded that the fluorescence loss by pyranine in the titration experiments was 
due to the formation of a water-soluble complex, but not to the complex precipitation. 
Figure 2.2: UV−vis (A) and Fluorescence (B, ex = 405 nm) Spectra for Pyranine: (a) 2.67 
μM solution of pyranine in 1% of DMSO in PBS. PBS with the same amount of DMSO 
was used as a blank solution in UV−vis; (b) 2.67 μM pyranine, 10 μM cyclen 1 solution in 
1% solution of DMSO in PBS. A 10 μM solution of cyclen 1 in 1% of DMSO in PBS was 
used as a blank in UV−vis. The arrow directions show the change of the property upon 
complexation. 
A B A B 
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 While the insolubility of a pyranine-cyclen 1 complex precluded its full structural 
characterization, a series of control experiments demonstrated the importance of all elements 
present in cyclen 1.  Thus, neither cyclen tetra-NH-Boc 3 nor the monomer 4 affected pyranine 
emission at concentrations up to 100 μM (Chart 2.2).  These results suggest recognition of 
pyranine rather than a simple electrostatic interaction of pyranine with cyclen 1, as well as the 
importance of four binding arms in cyclen 1.  With the solvophobic effect identified as a primary 
driving force for the complexation of pyranine by cyclen 1, the cyclen tetraphenylthiourea 2 was 
expected to show a weaker binding to pyranine.  Indeed, the assessed Ka value (9.2 ± 1.3) x 10
5
 
M
-1
 for the cyclen 2-pyranine complex was 3 times smaller than that for the cyclen 1-pyranine 
complex. 
To show specificity of cyclen 1 toward the pyranine structure, the affinity of cyclen 1 to 
several other dyes in PBS was evaluated.  Four different categories of dyes were tested.  The first 
category combines the pyrene-based 1,3,6,8-tetrasulfonic acid (PTA) and 8-aminopyrene-1,3,6-
trisulfonic acid (APTS) with a topology similar to that of pyranine.  The PTA molecule is 
decorated with four sulfonic groups in place of substituents of pyranine, whereas the amino 
group of the APTS molecule conceptually replaces the OH group of pyranine.  The next category 
was represented by 8-aminonaphthalene 1,3,6-trisulfonate (ANTS).  This dye features a 
naphthalene core in place of pyranine’s pyrene and is decorated with the same periphery as the 
APTS molecule.  The third category of dyes combines anionic fluorescein-based dyes 5-CF, 6-
CF, and calcein.  Whereas the electronic nature of the substituents in these dyes is similar to 
those found in pyranine, the central cores of these dyes lack pyranine’s planarity and extended 
conjugation.  Finally, the cationic dye safranin O was chosen as a negative control to 
demonstrate that the fluorescence loss was not due to a nonspecific quench.  The test of binding 
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for these model dyes was performed using fluorescence, UV-vis, and microcalorimetry titrations.  
The results of binding assays for selected dyes are summarized in Table 2.2. 
Both APTS and PTA dyes produced complexes with cyclen 1 (Figure 2.3A).  While the 
Ka value for the PTA-cyclen 1 complex in PBS was almost identical to that of the pyranine-
cyclen 1 complex, a 3-fold drop in Ka value for the less-anionic APTS molecule was observed.  
This drop demonstrates the importance of electrostatic interactions in the cyclen 1-pyranine 
complex. 
  
Figure 2.3: Fluorometric Titrations of Various Dyes with Cyclen 1: (A) Fluorometric 
titrations of 50 nM PBS solutions of pyranine (triangles, ex 405 nm, em 510 nm), PTA 
(squares, ex 376 nm, em 403 nm), and APTS (diamonds, ex 424 nm, em 503 nm) with 
cyclen 1. Experimental data are normalized to the percentage of unbound dye 
fluorescence. Continuous lines represent best fits to a 1:1 binding model. Note that the 
three dyes show different extents of fluorescence loss upon binding to cyclen 1. Inset 
shows the extent of complexation calculated for the data points from the main Figure 2.3A 
as a function of cyclen 1 concentration. The point shapes denote the same dyes as in the 
main Figure 3A. (B) Fluorometric titration of 50 nM ANTS (ex 365 nm, em 515 nm) with 
cyclen 1 in PBS. No fitting to a binding model was attempted. 
 52 
 
 The ANTS dye has demonstrated binding to cyclen 1 as well; however, the titration 
results were drastically different from those for pyranine, PTA, or APTS dyes (Figure 2.3B).  
While all three pyrene-based dyes gradually lost their fluorescence during the course of the 
titrations, the fluorescence of ANTS dye initially increased and reached a 3-fold maximum of the 
original fluorescence at the cyclen 1 concentration of 2.5 μM.  Further increase of the cyclen 1 
concentration resulted in a decrease of ANTS fluorescence, which reached its original value at a 
cyclen 1 concentration of 20 μM.  Clearly, such binding behavior cannot be described using a 1:1 
binding model.
232
  Formation of bigger than 1:1 aggregates, complex precipitation, or the 
combination of both can account for such complexation behavior.  The observed fluorescence 
loss of ANTS is not due to the increased optical density of the solution at the excitation 
wavelength, as this optical density never exceeded the value of 0.05.
154
  Since the ANTS-cyclen 
1 binding was not the main objective of the present study, no further attempt to clarify such 
binding behavior was undertaken.   
For the third category of dyes comprising fluorescein derivatives, no apparent binding by 
cyclen 1 was detected at up to 20 μM concentrations by fluorometric and UV-vis titration 
experiments.  6-CF lost 9% of its fluorescence in the presence of 20 uM cyclen 1.  Some binding 
of 6-CF to cyclen 1 is possible; however, low solubility of cyclen into a 1:1 isotherm within the 
range of available cyclen 1 concentrations gave a value of 5 x 10
3
 M
-1
 as a highest estimate for 
the Ka of the 6-CF-cyclen 1 complex.  For calcein, the most anionic dye within this category, the 
possibility of binding was also tested by ITC in methanolic solution.  These ITC experiments 
revealed small, compared to pyranine, gradually decreasing negative enthalpy of interaction 
without pronounced stoichiometric inflection points (Figure 2.1, parts C and D).  This heat 
emission can be well explained by protonation of the basic cyclen 1 by the acidic calcein.  The 
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apparent absence of binding for fluorescein derivatives demonstrates the crucial importance of 
the planar conjugated core of the pyrene (and naphthalene)-based dyes for their recognition by 
cyclen 1. 
 As expected, no binding of the cationic dye safranin O by cyclen 1 was detected by UV-
vis and fluorometric experiments. 
 2.4.4 Applicability of Cyclen 1 to Biomembrane Assays 
To validate the applicability of cyclen 1 to the membrane leakage assay, we performed 
experiments with the typical defect-forming peptide, melittin, and a typical ion channel forming 
peptide, gramicidin.
233, 234
  As expected, the pH-stat experiments on pyranine-loaded LUVs 
showed high, yet almost indistinguishable, activity of these peptides (Figure 2.4A).  The 
application of these peptides to the same population of LUVs along with cyclen 1 clearly 
revealed the difference in the two peptides’ mechanisms of action (Figure 2.4B).  Whereas little 
loss of pyranine emission was observed for gramicidin (trace a, pink line), a significant loss of 
emission was observed for melittin (trace b, blue line) when cyclen 1 was applied to the 
extravesicular buffer.  A steady fluorescence quench observed in the presence of melittin reflects 
the kinetics of pyranine release rather than the kinetics of cyclen 1-pyranine complexation.  
Indeed, the experiment where melittin was injected first and cyclen 1 was added after 4 minutes 
revealed a rapid quench of fluorescence, suggesting that most of the dye had been released by 
that time (trace c, green line).  Both traces b and c are almost identical at longer times, indicating 
that the amount of released pyranine was independent of cyclen 1. 
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Figure 2.4: Fluorescence Spectra of pH-stat and Membrane Leakage Assays: (A) pH-
stat assays in the absence of cyclen 1 performed on pyranine-loaded LUVs with 1 μM 
gramicidin (a, blue trace) and 5 μM melittin (b, pink trace). I
460
/I
405
 was monitored as 
function of time. (B) Membrane leakage assays performed on the same LUVs with 
cyclen 1. I
405
 was monitored as function of time. Color code and time events:  blue 
trace (a) 10 μM cyclen 1 at 60 s, 1 μM gramicidin at 100 s; pink trace (b) 10 μM 
cyclen 1 at 60 s, 5 μM melittin at 100 s; green trace (c) 5 μM melittin at 60 s, 10 μM 
cyclen 1 at 300 s. Termination at 500 s:  0.5% Triton X-100. 
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Unfortunately, cyclen 1 has found only limited applicability in the detection of 
endovesiculation.  Unlike with the membrane leakage assay, where all the dye was entrapped in 
liposomes and any measurable change in fluorescence was sufficient for the event detection, the 
endovesiculation detection required a fluorescence quench of large amounts of extravesicular 
dye in the presence of small amounts of the dye entrapped in LUVs.  Only the quenchers that 
suppress the fluorescence of the dye completely can be utilized in this assay.  The high 
concentration of DPX used in the currently employed endovesiculation detection assay is due to 
the low affinity of DPX to pyranine.  The assessed affinity of DPX to pyranine in PBS solution 
gave a Ka value of (1.2 ± 0.2) x 10
3
 M
-1
, which is three orders of magnitude lower than the Ka 
value for the pyranine-cyclen 1 complex formed under identical conditions.  However, the 
ultimate quenching efficiency of DPX toward pyranine exceeds 99.7%,
25
 whereas the quenching 
efficiency of cyclen 1 is not that high.  Our titration experiments showed that the cyclen 1-
pyranine complex has an intrinsic fluorescence of approximately 9% of the fluorescence of 
complex-free pyranine. 
 To increase the quenching efficiency of cyclen 1, we adopted a new protocol for the 
detection of endovesiculation.  Three sets of 600 nm EYPC LUVs containing 0, 20, and 90 μM 
solutions of pyranine in 100 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES)/100 mM NaCl buffer (pH = 7.1), respectively, were prepared and suspended in a 90 
μM solution of pyranine in HEPES buffer.  These three sets were used to mimic 0, 22, and 100% 
endovesiculation extent.  A 20 μL aliquot of each population of liposomes was diluted with 2 mL 
of pyranine-free HEPES buffer and treated with 20 μL of a 4 mM solution of cyclen 1 in DMSO.  
Cyclen 1 was not fully soluble at this 40 μM concentration, and precipitate was formed.  
However, there was an apparent interaction of pyranine at the surface of microcrystals formed by 
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cyclen 1, resulting in more efficient removal of the dye from solution and fluorescence quench.  
Because of the noise and fluorescence produced by the precipitated cyclen 1 – pyranine complex, 
the solutions of LUVs were filtered through a cotton layer prior to the fluorometric experiments 
(Figure 2.5). 
 
 The emission spectra produced by these three sets of LUVs in the absence of cyclen 1 
were almost indistinguishable due to the high extravesicular concentration of the dye (Figure 
2.5A).  The levels of the residual fluorescence for these sets of LUVs after the treatment with 
cyclen 1 were different and qualitatively consistent with the amounts of the dye entrapped inside 
(Figure 2.5B).  LUVs containing no pyranine showed 3.1% fluorescence intensity in the absence 
of cyclen 1.  LUVs containing 20 and 90 μM solutions of pyranine showed 3.7% and 5.4% 
original fluorescence intensity, respectively.  These results were reproducible with the accuracy 
of ±20% when the time between the addition of cyclen 1 and solution filtration was fixed at 5 
Figure 2.5: Emission Spectra for Three Sets of Liposomes Containing Different 
Amounts of Pyranine: (A) Emission spectra (ex 405 nm) recorded for three sets of 
liposomes containing 0, 20, and 90 μM solutions of pyranine and suspended in the 
buffer containing 90 nM of pyranine. (B) Emission spectra for the same sets of 
liposomes after the treatment with cyclen 1. The scale unit in (B) is the same as in (A). 
Color code for the traces in both (A) and (B):  pink (a) LUVs containing 90 μM 
pyranine solution; blue (b) LUVs containing 20 μM pyranine solution; green (c) LUVs 
containing no pyranine. 
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minutes.  Longer incubations resulted in lower levels of fluorescence intensity, although the 
relative values were close to those observed at 5 minutes of incubation. 
 Even with the advantage of low quencher concentration, this new endovesiculation 
detection assay cannot replace the currently existing DPX-based assay for several reasons.  First, 
an additional filtration step is required, which lowers the accuracy of the results.  Second, there is 
a kinetic dependence of the fluorescence quench.  Third, the results cannot be internally 
normalized after the filtration step.  In the DPX-based assay, the fluorescence extent is 
normalized to the residual fluorescence observed after the lysis of LUVs by detergent.  The 
filtration step in a cyclen 1-based assay removes the quencher, and subsequent lysis does not 
result in a fluorescence change, whereas the external normalization with the residual 
fluorescence of pyranine-free LUVs lowers the accuracy of experiment.  Finally, the incomplete 
quench of the external pyranine emission drastically limits the sensitivity of the cyclen 1-based 
assay.  With all these disadvantages, the cyclen 1-based assay can still be used as a control to 
remove the ambiguity imposed by a high concentration of the quencher in the DPX-based assay. 
 The limitations in applicability of cyclen 1 to biomembrane assays arose from its low 
solubility and insufficient quenching efficiency.  We plan to improve these characteristics in the 
future by covalently attaching DPX and poly(ethylene glycol) (PEG) units to the cyclen-thiourea 
core.  These modifications should afford a pyranine receptor combining all features essential for 
membrane assays, and this is the focus of our ongoing study. 
  In conclusion, we have rationally designed and synthesized a pyranine receptor cyclen 1.  
Cyclen 1 revealed a high affinity to pyranine dye under near-physiological conditions.  Utilizing 
this affinity and the impermeability of cyclen 1 to the bilayer membrane, we have developed a 
new membrane leakage assay that is fully compatible with the pH-stat assay.  Applying the 
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methods described herein, it becomes possible to distinguish between ion transport and 
membrane leakage within a single set of experiments.  We have also shown some limited 
applicability of cyclen 1 to the detection of endovesiculation and we are currently working on the 
synthesis of the pyranine-specific fluorescence quencher that is compatible with the 
endovesiculation assay.  
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3.1 Abstract 
A new methodology for the detection of lipid flip was developed.  This methodology 
relies on the quenching of the fluorescence of the cascade-blue-labeled lipid through complex 
formation with a membrane-impermeable cyclen-tetranaphthalenethiourea synthetic receptor for 
this dye.  The high affinity of the receptor to the cascade-blue label allows the use of micromolar 
concentrations of this receptor during the experiment.  At these low concentrations, the receptor 
does not interfere with the membrane integrity and, therefore, renders this new methodology less 
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invasive to the model and cell membranes than commonly utilized 7-nitro-1,2,3-benzoxadiazol-
4-yl (NBD)-dithionite methodology.  Unlike with the NBD-dithionite assay, where the 
fluorescence quenching of the NBD group is achieved through its chemical modification, this 
new assay relies on the noncovalent interactions between cascade-blue label and the receptor.  
Therefore, the quenching can be reversed by either competitive displacement of the lipid-
attached label with a water-soluble substrate, or by enzymatic degradation of the receptor leading 
to the label release and fluorescence dequenching.  We demonstrate that this new methodology is 
suitable for the study of lipid flip in both model spherical bilayer membranes and in-vitro 
experiments. 
3.2 Introduction  
Lipid flip detection assays allow monitoring of the activity of enzymes known as 
flippases, floppases and scramblases
77
 and their fully synthetic
80-83
 or peptide analogues.
84, 85
  
These enzymes control the transmembrane distribution of lipids in cells and are responsible for 
membrane asymmetry.  Lipid translocation mediated by these enzymes is associated with 
apoptosis
64-68
 and blood clotting.
235, 236
  Synthetic molecules capable of lipid flipping can be 
considered as developmental therapeutics for several disorders,
86, 87
 such as Scott syndrome and 
vascular complications in Alzheimer’s disease.88, 89  Furthermore, flip of cationic lipids may 
greatly improve the efficiency of nonviral gene delivery systems.
90
  To date, three major assays 
are utilized for the monitoring of lipid flip in model spherical bilayers (liposomes).  The first 
method relies on the flip of transferable fluorescent 7-nitro-1,2,3-benzoxadiazol-4-yl (NBD)-
labeled lipid from the donor liposomes to the acceptor liposomes containing nontransferable 
rhodamine-labeled lipid that serves as a fluorescence quencher.
164
  The second methodology is 
based on removal of the fluorescent lipid
165
 from the bilayer outer leaflet by incubation with 
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serum albumin.
166
  The most conventional way for detection of flippase activity is based on the 
irreversible quenching of the fluorescence of NBD-labeled lipids in cells
167
 or liposomes
168, 169
 
with 10-60 mM sodium dithionite (Na2S2O4, Scheme 3.1A).  The extent of lipid flip is assessed 
from the residual fluorescence of liposomes after the application of the quencher.  Because of its 
anionic character, dithionite exhibits low permeability to the hydrophobic bilayer membrane and 
therefore does not rapidly quench the fluorescence of the lipid located on the inner bilayer leaflet 
but quickly quenches the fluorescence of lipid residing on the outer leaflet.  The assay has 
numerous intrinsic deficiencies arising from the high concentration of the quencher required for 
the assay, the reductive nature of this reagent, and some permeability of the quencher to the 
bilayer membrane.  In addition, it has been shown recently that  sodium dithionite diffusion 
through the bilayer is similar or faster than that of unfacilitated lipid flip.
170
  Potentially, 
dithionite can reduce the disulfide cross-links found in some flippases.  For example, wild type 
human P-glycoprotein, (Pgp), which is a known flippase,
171
 facilitates the lipid flip to a lesser 
extent then Pgp treated with the reducing agent because of inhibitory disulfide cross-links 
between nucleotide binding sites.
172
  In contrast, the activity of human scramblase protein is 
suppressed by reducing reagents because of the reduction of disulfide cross-links.
173
  These 
examples demonstrate that dithionite may affect the flipping activity of enzymes in a dual way 
and, therefore, cannot be used in the real time monitoring experiments.  
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Scheme 3.1: Schematic Representation of Lipid Flip Detection Assay and 
Structures of the Compounds used in the Present Study: (A) Liposomes containing 
fluorescently labeled lipids are treated with membrane-impermeable quencher.  
Alterations in the residual fluorescence of the lipids from inner bilayer leaflet 
serve as the measure of lipid flip.  (B) Structures of the receptor 1 and 
fluorescently labeled lipids used in the present study. 
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3.3 Experimental Procedures 
 3.3.1 General 
The 
1
H NMR spectra were recorded on a Varian AS400 instrument operating at 400.130 
MHz or Varian Mercury instrument operating at 299.865 MHz.  Chemical shifts are reported in 
ppm relative to the residual protonated solvent peak.  The mass spectra were recorded on a 
Micromass Q-TOF™ 2 instrument (Manchester, UK) using the electrospray technique (positive 
and negative modes were used).  The samples were introduced into mass spectrometer using a 
flow rate of 10 μL/min, the needle voltage was set at 3500 V with ion source at 110 oC, and the 
cone voltage was set at 35 V.  All spectrophotometric experiments were carried out on a 
Fluoromax 3 (Jobin-Yvon/Horriba) spectrophotometer.  The pH of solutions was monitored with 
a Corning 350 pH/ion analyzer, using a Ag/AgCl pH-sensitive electrode (Accumet).  
Chromatography was performed using 60-200 mesh silica purchased from Baker and 40-120 μm 
Sephadex G-75 purchased from Aldrich.  Thin layer chromatography was performed on 
Kieselgel 60 F254 and Uniplate
™
 Silica Gel GF silica-coated glass plates and visualized by UV 
and I2.  High-pressure extrusion was performed on the Avanti
™
 mini-extruder with a 0.1 μm 
polycarbonate membrane.  All chemicals, solvents and dyes were purchased from Aldrich, 
Sigma, Fluka and Invitrogen.  Egg yolk phosphatidylcholine, L-alpha-dioleoyl 
phosphatidylethanolamine (DOPE), N-(7-nitro-2-1,3-benzoxadiazol-4-yl)-(1,2-dioleoyl-sn-
glycero-3)-phosphoethanolamine (NBD-PE) and N-(1-pyrenesulfonyl)-(1,2-dioleoyl-sn-
glycero)-3-phosphoethanolamine (lipid 6) were purchased from Avanti Polar Lipids. 
 3.3.2 Synthesis 
Cyclen 1 was synthesized as previously reported.
237
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Lipid 5 was synthesized in a one-step procedure as following: 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine (DOPE) (33 mg, 0.044 mmol) and 1-pyrenebutyric acid (68 mg, 0.177 
mmol, 4-fold excess) were dissolved in 2 mL of dimethylformamide (DMF).  A 1 mL solution of 
N,N’-dicyclohexylcarbodiimide (DCC) (37 mg, 0.177 mmol, 4-fold excess) and 4-
dimethylaminopyridine (22 mg, 0.177 mmol, 4-fold excess) was added dropwise at 0
◦
C.  The 
reaction was allowed to come to room temperature and was stirred for 12 hours.  The solution 
was removed under reduced pressure and purified by column chromatography [silica gel, 
gradient of chloroform (CHCl3) and methanol (MeOH)] yielding 9 mg of pure product (0.009 
mmol, 20%).  
1
H NMR (CDCl3, δ):  8.18 (br s, 1H), 7.82-8.10 (m, 7H), 7.72 (br s, 1H), 5.28 (br 
s, 4H), 4.34 (br s, 1H), 4.12 (br s, 2H), 4.02 (br s, 2H), 3.94 (br s, 2H), 3.50 (s, 8H), 3.28 (br s, 
3H) 2.50-0.80 (br m, 59H).  MS (ESI, high-resolution) [M]
-
: 1012.5525 calculated for 
C61H91NO9P
-
 1012.644. 
Lipid 7 was synthesized in a two-step procedure: 
i) 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (50 mg, 0.067 mmol) was dissolved in 5 mL 
of methylene chloride (CH2Cl2), and diisopropylethylamine (20 μL, 0.115 mmol, 1.7-fold 
excess) was added.  A solution of bromoacetyl bromide (20 μL in 1 ml of CH2Cl2, 0.23 
mmol, 3.4-fold excess) was added to the reaction mixture dropwise.  The reaction mixture 
was stirred for 12 hrs at room temperature, and the solvent and excess reagents were 
removed under reduced pressure to afford crude N-(2-bromoacetyl)-1,2-dioleoyl-sn-glycero-
3-phosphoethanolamine.  The crude product was purified by column chromatography (silica 
gel, methanol:CH2Cl2 6:94) to give 53 mg of the pure product (0.061 mmol, 91%).  
1
H NMR 
(CDCl3, δ): 10.36 (br s, 2H), 5.33 (app p, 2H, J = 2.4 Hz), 4.39 (br s, 1H), 4.13 (br s, 1H), 
3.93 (br s, 2H), 3.79-3.65 (m, 4 H), 3.18-3.05 (m, 4H), 2.38-2.30 (m, 2H), 2.00 (app q, 4 H, J 
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= 5.7 Hz), 1.73 (m, 2H), 1.65-1.15 (m, 48 H), 0.87 (app t,  6 H, J=5.7 Hz). MS (ESI, high-
resolution) [M]
-
: 862.5907, calcd for C43H78BrNO9P
-
 862.4598. 
ii) N-(2-bromoacetyl)-1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (10 mg, 0.011 mmol) 
was dissolved in 2 mL of acetone, potassium carbonate (10 mg, 0.072 mmol, 6.5-fold excess) 
was added, and the reaction mixture was stirred for 40 min at room temperature.  Then, 8-
hydroxypyrene-1,3,6-trisulfonic acid sodium salt (10 mg, 0.019 mmol, 1.7-fold excess) was 
added, and the reaction mixture was stirred for 48 hours under reflux.  The solvent was 
evaporated under reduced pressure, and the residual solid was partitioned in chloroform-
water.  The organic layer was separated, and the solvent was removed under reduced 
pressure. The crude product was purified by the size exclusion chromatography (Sephadex 
G-75 as solid phase, Millipore water as mobile phase) to afford 4 mg of pure lipid 7 
(potassium salt, 0.0029 mmol, 26%).  
1
H NMR (CDCl3, δ): 7.70 (m, 1H), 7.51 (m, 1H), 7.10 
(br s, 1H), 6.96 (br s, 1H); 6.82-6.73 (m, 2H), 5.37 (app s, 2H), 4.69 (app s, 1H), 4.38-4.33 
(m, 4 H), 4.15 (br s, 2H), 3.89 (s, 1H), 3.62 (br s, 2H), 2.36-2.25 (m, 2H), 2.0 (m, 4H), 1.66-
1.10 (m, 48H), 0.72 (app t, 6H, J= 5.7 Hz). (ESI,) [M]
2-
: 658.4895, calcd for 
C59H85K2NO19PS3
2- 
658.1948. 
 3.3.3 Preparation of Symmetric Liposomes for Lipid Flip Monitoring Assays 
Egg yolk L-alpha-phosphatidylcholine (EYPC ethanol solution, 60 μL, 79 μmol) and 
chloroform solution of labeled lipid (NBD-PE, lipid 5, 6 or 7, 20-50 μL, 79 nmol) were dissolved 
in a CHCl3/MeOH mixture to give a 1:1000 mixture of labeled lipid:EYPC, the solution was 
evaporated under reduced pressure, and the resulting thin film was dried under high vacuum for 
2 h.  The lipid film was hydrated for 40 min in 1.2 mL of sodium phosphate buffer (PBS), (10 
mM sodium phosphate, pH = 6.4, 100 mM NaCl).  During hydration, the suspension was 
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submitted to 3 freeze-thaw cycles (dry ice/acetone, water at room temperature).  The resulting 
suspension of large multilamellar vesicles (1 mL) was submitted to high-pressure extrusion at 
room temperature.  The large unilamellar vesicle (LUV) suspension was purified by size 
exclusion chromatography (SEC) (stationary phase: Sephadex G-75, mobile phase: sodium 
phosphate buffer of the same composition) and diluted with the same sodium phosphate buffer to 
give a stock suspension with the total lipid concentration of 33 mM (assuming 100% of lipid was 
incorporated into liposomes).  
 3.3.4 Preparation of Asymmetric Liposomes with Excess of Lipid 7 in the Outer Bilayer 
Leaflet 
The stock suspension of liposomes (30 μL), symmetrically labeled with lipid 7 (see 
above) was diluted with 2 mL of phosphate buffer (10 mM sodium phosphate, pH = 6.4, 100 
mM NaCl), and a solution of lipid 7 in DMSO (10 μL, 0-100 μM) was added.  This suspension 
was preincubated for 10 minutes prior the experiments.  The immediate fluorescence monitoring 
resulted in lower initial fluorescence levels, probably due to the slow incorporation of lipid 7 into 
the liposomal exterior from the individual lipid 7-formed liposomes and self-quenching of the 
lipid 7 fluorescence in these liposomes due to high local concentration of the cascade-blue 
label.
238
 
 3.3.5 Kinetic Fluorescence Quenching Experiments with Symmetrically Labeled LUVs 
In a typical experiment, 50 μL of LUVs labeled with lipid 5, 6, 7 or NBD-PE (stock 
solution) was suspended in 1.95 mL of the phosphate saline buffer (10 mM sodium phosphate, 
pH = 6.4, 100 mM NaCl) and placed into a thermostated spectrophotometric cell.  The 
suspension of liposomes was gently stirred throughout the entire course of experiment.  The 
emission of labeled lipid (397 nm for lipids 5 and 6, 434 nm for lipid 7, and 534 nm for NBD-
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PE) was monitored with the excitations at 317, 354, 402 and 460 nm respectively.  The emission 
and excitation slits of the spectrophotometer were set at 5 nm, time increments were set at 1 s, 
and the integration time was set at 1 s.  The temperature of the spectrophotometric cell was set at 
25
o
C.  During the experiment, 20 μL of a 0-5 mM DMSO solution of cyclen 1 or 1 M aqueous 
solution of sodium dithionite was added through the injection port.  At the end, the experiments 
were terminated by the injection of 40 μL of 20% aqueous solution of Triton X-100.  In the case 
of experiments with variable amounts of Triton X-100, 40 μL injections of the corresponding 
Triton X-100 aqueous solutions were performed.  Binding constant and the maximum emission 
loss with the confidence interval values were computed using a homemade nonlinear regression 
curve-fitting program.  The 1:1 binding model was used. 
 3.3.6 Kinetic Fluorescence Quenching Experiments with Asymmetrically Labeled LUVs  
These experiments were carried out analogously to section 3.3.5, except that the 
suspension of asymmetric LUVs described above were used without further dilution.  
 3.3.7 Cell Culture 
HEK 293 cells were obtained from ATCC (Manassas, VA) and maintained at 37
°
C with 
5% CO2 in an incubator.  The culture medium used was minimum essential medium (MEM) 
supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 g/mL 
streptomycin (all from Invitrogen Corp, Carlsbad, CA).  A2780 human ovarian carcinoma cells 
were a generous gift from Dr. Stephen Williams, Ovarian Cancer Program, Fox Chase Cancer 
Center, Philadelphia, PA.  A2780 cells were cultured in Roswell Park Memorial Institute (RPMI) 
(Gibco: Invitrogen, Carlsbad, CA) 5% FBS, 5% BCS (bovine calf serum), 0.25% 
penicillin/streptomycin.  Cells were routinely passaged at 80-90% confluency.  
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 3.3.8 Confocal Imaging 
  The activity of the compounds tested was evaluated using confocal microscopy.  HEK 
293 cells were plated on 12-mm round glass cover slips pretreated with poly-D-lysine (BD 
Biosciences, Bedford, MA).  Prior to experiment, the cover slips with the cells were washed with 
PBS, transferred to a small experimental chamber (Warner Instruments,
 
Hamden, CT) mounted 
on the stage of an Olympus confocal microscope (Olympus FV 300, Tokyo, Japan) equipped 
with a x40/0.95 water immersion objective and cooled, charge-coupled
 
device camera.  The bath 
solution contained (in mM): 140 NaCl, 3 KCl, 2 MgCl2, 25 D-glucose, 10 HEPES and 2 CaCl2, 
with pH adjusted to 7.4 with NaOH (all from Sigma Aldrich (Atlanta, GA)).  Cells were 
visualized and selected for an experiment using the brightfield system.  The excitation light to 
the preparation was supplied from an LD-405 (Olympus) diode laser.  The ultraviolet excitation 
wavelength was controlled by a mirror unit that filtered the excitation at 360-370 nm and the 
emission at 420-460 nm levels.  Digital images (640x480 pixels) were obtained and processed 
using Fluoview v.5.0 software (Olympus), and preset settings for DAPI (4,6-diamidino-2-
phenyl-indole) were used.  Experiments were performed at room temperature (22-25
o
C).  During 
the experiment, 10 μL of 300 μM DMSO solution of lipid 5 or 7 was added to the bath solution 
(1 mL), followed by the addition of 10 μL of 2.5 mM DMSO solution of cyclen 1. 
 3.3.9 Cell Growth Inhibition Assays 
For the MTT (3-(4, 5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) assay, 
A2780 human ovarian carcinoma cells were plated at a density of 6,500 cells per well in a 96-
well plate and incubated overnight at 37
°
C in a 5 % CO2 atmosphere.  Stock solutions of sodium 
dithionite, 100 mM in media, and cyclen 1 compound, 5 mM in DMSO, were made fresh prior to 
each use.  Cells were treated at 10 mM and 25 M concentrations of sodium dithionite and 
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cyclen 1, respectively, for 72 h.  After medium removal, cells were washed twice with cold PBS 
and incubated with MTT (2 mg/mL in PBS) for 3 h.  The excess MTT (Sigma, St. Louis, MO) 
was then removed, the dye dissolved in 100 μL of DMSO (Sigma, St. Louis, MO), and 
absorbance was read on a Molecular Devices Vmax kinetic microplate reader at 540 nm.  
Transmission images of the cells were obtained on an Olympus IX70 microscope, using 20x 
magnification. 
3.4 Results and Discussion 
 3.4.1 Identification of Appropriate Components for the Lipid Flip Detection Assay 
We have recently developed a synthetic receptor, cyclen thiourea 1 (Scheme 3.1B), 
which is capable of selective binding of anionic pyrene-based dyes with submicromolar affinity 
under near physiological conditions.
237
  This receptor is impermeable to the bilayer membrane 
and quenches 90-99% of the fluorescence of pyrene-based dyes.  We hypothesized that this type 
of receptor should be able to quench the fluorescence of the accessible portion of pyrene-labeled 
phospholipids residing on the outer leaflet of the bilayer membrane of liposomes upon its 
exogenous application.  Such quenching of the fluorescence of the outer portion of the labeled 
lipid should provide the basis for a new lipid flip detection assay.  The high affinity of cyclen 1 
to the anionic pyrene-based dyes should warrant the low micromolar concentration range 
required for the fluorescence quenching and therefore provide less invasive conditions for the 
lipid flip detection than in the otherwise analogous NBD-dithionite assay. 
In order to verify the validity of such an approach we synthesized two pyrene-labeled 
phospholipids (Scheme 3.1B): dioleoylphosphatidylethanolamine-pyrenebutyric acid 5 and 
dioleoylphosphatidylethanolamine-hydroxypyrene trisulfonate 7, and also tested the 
commercially available dioleoylphosphatidylethanolamine-pyrene-sulfonamide 6.  Previously, 
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we identified the hydrophobic effect rather than electrostatic or hydrogen-bonding interactions as 
the major driving force for the complex formation between pyrene-based dyes and cyclen 1.  
Therefore it was reasonable to expect that neutral pyrene labels of phospholipids 5 and 6 will 
also bind to cyclen 1. 
Phospholipids 5 and 6 feature a neutral pyrene label tethered by linkers of variable 
length.  Phospholipid 5 was the most hydrophobic lipid among three probes because of nonpolar 
nature of pyrene group and substantially higher hydrophobicity of amide linker than that of 
sulfonamide linker of lipid 6.
239
  Therefore, lipid 5 was expected to diffuse across bilayer 
membranes with the highest rate, whereas the trianionic character of the cascade-blue label
240
 in 
the phospholipid 7 was expected to prevent any unmediated diffusion of this lipid across the 
membrane. 
First, we prepared three sets of large unilamellar liposomes (LUVs) from egg yolk 
phosphatidylcholine (EYPC) containing 0.1 mol% of the pyrene-labeled lipids 5-7 evenly 
distributed between the inner and outer leaflets of the bilayer.  The emission spectra for the 
suspensions of these three sets of liposomes were recorded in the presence (20 μM) and in the 
absence of cyclen 1.  No apparent changes in the fluorescent spectrum were observed upon 
addition of cyclen 1 to the LUVs labeled with lipid 6.  This is probably because the short length 
of the linker connecting the pyrene label to the phospholipids caused the immersion of the 
pyrene moiety into the hydrophobic region of the bilayer thus making this label inaccessible to 
cyclen 1.  
The identical experiments with LUVs containing phospholipids 5 and 7 revealed 46% 
and 41% fluorescence intensity loss, respectively, upon addition of 20 μM cyclen 1 (Figure 3.1).  
However, the kinetic experiments, where the maximum fluorescence intensity was monitored as 
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a function of time, revealed that the fast loss of 46% of fluorescence by LUVs containing lipid 5 
was followed by a somewhat slower phase of quenching resulting in the overall 80% loss of the 
fluorescence in only 20 minutes (not shown).  These results can be explained by the high rate of 
unmediated diffusion of lipid 5 across the bilayer membrane and subsequent quenching of the 
fluorescence of the exposed lipid by extravesicular cyclen 1.  However, the secondary phase of 
the fluorescence quenching in LUVs labeled with polar phospholipid 7 was negligibly slow, 
consistent with the expected slow unmediated flipping rate for this lipid.  The kinetic quenching 
experiments were terminated by application of 0.5% of the detergent Triton X-100, which 
resulted in a complete lysis of LUVs and exposure of the inaccessible portion of the fluorescent 
lipids to cyclen 1.  
Application of cyclen 1 to LUVs labeled with lipid 7 and lysis of these LUVs with the 
detergent Triton X-100 gave 87% of fluorescence quenching.  However, the fluorescence of the 
LUVs labeled with lipid 5 increased upon application of Triton X-100 and even exceeded the 
original fluorescence of the cyclen 1-free suspension of LUVs.  This is most likely because of 
repartitioning of nonpolar pyrene headgroup of lipid 5 into the hydrophobic core of the Triton X-
100 micelles, accompanied by the decomposition of the complex formed from lipid 5 and cyclen 
1.  This observation made lipid 5 a less attractive probe for lipid flip monitoring, and most of the 
further work was carried out with the polar lipid 7.  
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 3.4.2 Kinetic Experiments under Lipid Flip Mimicking Conditions 
In order to find the optimal concentration of cyclen 1 required for the quenching of the 
fluorescence of lipid 7, we carried out a series of kinetic titration experiments, where the 
emission intensity of LUVs treated with variable amounts of cyclen 1 was monitored as a 
function of time (Figure 3.2A).  Application of variable amounts of cyclen 1 resulted in various 
degrees of fluorescence quenching, however, the apparent saturation was observed at cyclen 1 
concentrations above 10 μM. 
The extent of fluorescence quenching by cyclen 1 can be interpreted in terms of complex 
formation between lipid 7 and cyclen 1, therefore, the fluorescence data were fitted into the 
binding isotherm (Figure 3.2B, 1:1 stoichiometry was assumed).  The kinetics of fluorescence 
quenching clearly consisted of two phases, where the primary fast phase was likely due to the 
interactions of the outer leaflet portion of lipid 7, and the slower phase was due to the lipid 
flipping from the inner leaflet into the outer leaflet, followed by complex formation.  The 
secondary phase was almost linear for all traces, therefore, linear fit of the data points in the 
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Figure 3.1: Fluorometric Characterization of Interactions of Cyclen 1 with 
Fluorescently-Labeled LUVs: (A)  Emission spectra (ex = 317 nm) of LUVs labeled 
with lipid 5 in the absence (top spectrum) and in the presence (bottom spectrum) of 20 
μM cyclen 1.  (B) Emission spectra (ex = 402 nm) of LUVs labeled with lipid 7 in the 
absence (top spectrum) and in the presence (bottom spectrum) of 20 μM cyclen 1.  
LUVs in all experiments were suspended in 1% DMSO in the phosphate saline buffer. 
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secondary phase time interval (300-800 s for all traces) and extrapolation to the time of the 
cyclen 1 injection (60 s in all traces) allowed us to assess the extent of lipid quenching in the 
primary phase accurately.  These data were fit into the binding isotherm, and the maximum 
fluorescence quenching and apparent binding constant Ka were assessed.  The found values for 
these two parameters were 46±2% and 4.8(±1.5) x10
5
 M
-1
, respectively.  A similar data fit was 
performed for the fluorescence intensity values after lysis of LUVs by Triton X-100.  The 
corresponding values for the maximum fluorescence quenching and binding constant Ka were 
assessed as 92±4% and 2.1(±1.5) x 10
5
 M
-1
, respectively.  The maximum fluorescence quenching 
by cyclen 1 before and after the lysis of liposomes is consistent with the hypothesis that the 
membrane-impermeable receptor quenches 50% of the fluorescence in the symmetrically-labeled 
LUVs, whereas the similar values of Ka before and after the lysis suggest that the detergent 
produced little effect on the complex formation.  The assessed binding constant for the lipid 7 – 
cyclen 1 complex was approximately 10 times lower than that assessed for the complex of a 
water-soluble dye 8-hydroxypyrene-1,3,6-trisulfonic acid (HPTS) reported previously,
237
 
however, the affinity of cyclen 1 to the dye attached to the lipid remained high enough to allow 
the detection of lipid flip with micromolar concentrations of cyclen 1. 
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Figure 3.2: Kinetic Monitoring of the Fluorescence (ex = 402 nm, em = 434 nm) of LUVs 
Labeled with Lipid 7 in the Presence of Cyclen 1: (A) Fluorescence of symmetrically-labeled 
LUVs in the presence of variable amounts of cyclen 1.  From top to bottom the traces at 500 
s denote fluorescence of LUVs in the presence of 0 (green), 3.1(purple), 4.5(blue), 6.3(light 
blue), 12.5(red), 25(golden) and 50 (pink) (μM) cyclen 1.  Time events: 60 s: 20 μL of 0-5 
mM DMSO solution of cyclen 1 was injected into 2 mL of LUVs suspension; 900 s: 40 μL of 
aqueous 25% solution of Triton X-100 was injected.  (B)  Points in the upper trace (blue) 
correspond to the fluorescence intensity values from (A) extrapolated to the maxima of the 
fast quenching (see main text for explanation).  Points in the bottom trace (pink) correspond 
to the fluorescence intensity values after the lysis of LUVs with Triton X-100.  Continuous 
lines in both traces represent best fits to a 1:1 binding model. (C)  Kinetic monitoring of the 
fluorescence of LUVs asymmetrically labeled with lipid 7.  From bottom to top at 30 s traces 
denote LUVs containing 0.25 (dark blue), 0.31(golden), 0.38 (red), 0.5 (purple), 0.68 (sky 
blue) and 0.75 (green) μM (bulk concentration) lipid 7 in the outer leaflet and 0.25 μM lipid 
7 in the inner leaflet.  Time events: 60 s: 20 μL of 2 mM DMSO solution of cyclen 1 was 
injected into 2 mL of LUVs suspension; 900s: 40 μL of aqueous 25% solution of Triton X-
100 was injected.  (D)  Data from (C) after subtraction of the residual fluorescence and 
normalization to 100% of the fluorescence of symmetrical LUVs. 
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Next, we performed experiments with LUVs exhibiting asymmetry in the distribution of 
the labeled lipid between the inner and outer bilayer leaflets.  The residual fluorescence at the 
end of experiments increased as the total concentration of cyclen 1–lipid 7 complex increased.  
However, the ratio between fluorescence quenching upon application of 20 μM cyclen 1 and 
fluorescence quenching upon application of Triton X-100 changed proportionally to the excess 
of labeled lipid in the outer leaflet of the bilayer (Figure 3.2C).  Subtraction of the residual 
fluorescence and normalization of the fluorescence intensity to 100% of symmetrical LUVs gave 
a set of traces with the extent of cyclen 1-induced fluorescence quenching proportional to the 
amount of labeled lipid in the outer leaflet (Figure 3.2D).  At the same time, the extent of 
fluorescence quenching upon application of the detergent remained constant, consistent with the 
unchanged amount of labeled lipid residing on the inner leaflet of the bilayer.  These 
observations suggest that the proposed methodology is indeed suitable for the assessment of the 
lipid distribution between the inner and outer leaflets of liposomal membranes.  
In the envisioned mode of interaction between lipid 7 and cyclen 1, cyclen 1 binds to the 
cascade-blue label of lipid 7 at the surface of the bilayer membrane.  Therefore, it was possible 
that the receptor bound to the membrane was perturbing the integrity of this membrane, thus 
affecting the rate of the lipid flip.  In order to find whether this was the case, we performed an 
additional experiment with symmetrically labeled LUVs containing 0.5 mol % of lipid 7.  This 
five times higher concentration of lipid 7 would introduce five times more of cyclen 1 upon 
binding.  If cyclen 1 interferes with the integrity of the bilayer membrane, a different rate of lipid 
7 quenching in the secondary slow phase would be observed.  However, the kinetic trace 
obtained in the experiment with these new LUVs was identical (except the absolute fluorescence 
intensity) to that obtained for the LUVs labeled with 0.1 mol % of lipid 7, including the extent of 
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fluorescence quenching in the fast phase and the slope of the fluorescence quenching in the 
secondary slow phase.  Therefore, we concluded that cyclen 1 does not perturb the integrity of 
the bilayer membrane in the range of concentrations of cascade-blue label used in these 
experiments, and it does not affect the rate of the lipid flip. 
 3.4.3 Reversibility of Binding 
The NBD-dithionite lipid flip assay relies on the irreversible covalent modification of the 
NBD label by reduction of the nitro group to an amino group, which leads to the loss of 
fluorescence. In contrast, the pyrene-cyclen 1-based assay relies on the noncovalent and, 
therefore, potentially reversible interactions of the fluorescent label with the receptor. Two 
independent methods can be considered for such binding reversal: first, a competitive 
displacement of the fluorescent label, attached to the lipid with the water-soluble substrate for 
the same receptor and, second, degradation of the receptor leading to the release of the 
phospholipid label.  
The first method has a disadvantage where all the identified substrates for the receptor 
cyclen 1 are fluorescent dyes with spectral characteristics similar to that of cascade-blue label of 
lipid 7.  The largest spectral distinction, however, was found between the cascade-blue label of 
lipid 7 (ex = 402 nm, em = 434 nm) and its synthetic precursor, HPTS (ex = 405 nm, em = 510 
nm).   The displacement experiments, where a suspension of LUVs labeled with lipid 7 was 
originally treated with 5 µM cyclen 1 and then with 0-10 µM HPTS, demonstrated an increase of 
the fluorescence intensity at 434 nm (ex = 402 nm) upon addition of HPTS (Figure 3.3A).  Yet, 
a substantial contribution of the HPTS emission to the total intensity of the fluorescence at this 
wavelength made this approach nonpractical.  We are currently screening other potential 
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candidate molecules that might form strong complexes with cyclen 1 and displace cascade-blue 
label of lipid 7. 
To demonstrate the possibility for the second approach, we decided to enzymatically 
degrade cyclen 1.  The thiourea units of cyclen 1 are tethered to the cyclen scaffold via ester-type 
linkers, making cyclen 1 a suitable substrate for a variety of esterases.  In the course of the 
kinetic experiment, the fluorescence of LUVs labeled with lipid 7 was monitored as a function of 
time.  The application of 10 µM cyclen 1 resulted in the loss of 43% fluorescence.  Application 
of 150 U of porcine liver esterase resulted in a gradual increase of the fluorescence, which 
reached 90% of the original intensity in approximately 1.5 hours (Figure 3.3B).  This example 
demonstrates that the bound portion of lipid 7 can be released if required during the lipid flip 
monitoring experiment.  
0
25
50
75
100
125
410 430 450 470
I r
e
l, 
%
 
wavelength, nm 
40
60
80
100
0 2000 4000
I r
e
l, 
%
 
time, s 
b 
a 
c 
A B 
cyclen 1 
 esterase 
Figure 3.3: Reversibility of Cyclen 1-Lipid 7 Complexation: (A) Emission spectra of the 
LUVs labeled with lipid 7 (ex = 402 nm): a) spectrum of LUVs in the presence of 1% 
DMSO (blank experiment); b) spectrum of LUVs in the presence of 5 μM cyclen 1 and 1% 
DMSO; c) spectrum of LUVs in the presence of 5 μM cyclen 1, 1% DMSO and 5 μM 
HPTS.  The intensities were normalized to 100% of the emission intensity of cyclen 1-free 
set of LUVs (trace a) at 434 nm. (B) Kinetic monitoring of the fluorescence intensity of 
LUVs labeled with lipid 7 upon application of 10 μM cyclen 1, followed by the application 
of porcine liver esterase (150 U). 
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 3.4.4 Comparative Invasiveness of Cyclen 1 and Sodium Dithionite 
Another potential disadvantage of the NBD-dithionite assay can arise from the fact that 
dithionite is the anion of inorganic salt and can therefore be taken up by cellular transporters, for 
example sulfate-anion exchangers.
241
  Such internalization of dithionite would result in the 
reduction of the NBD-label residing on the inner leaflet of the bilayer and may lead to the false-
positives in the in vitro experiments.  A large molecule of cyclen 1 will unlikely be a substrate 
for cellular transporters; therefore, no such false positive identification of lipid flip activity 
should be expected.  We demonstrated this potential advantage of cyclen 1-based assay in an 
experiment with LUVs under ion-transport mimicking conditions.  It has been shown that 
detergents at sublytic (below CMC) concentrations form transient pores in the bilayer 
membranes that may allow passage of small molecules.
242-244
  Specifically, sublytic 
concentrations of Triton X-100 were shown to increase permeability of erythrocyte membranes 
to small ions (Na
+
, Cl
-
) but not to the relatively large molecules (glucose).
245
  We performed a 
parallel series of kinetic experiments with LUVs containing NBD-labeled phospholipid and 
LUVs labeled with lipid 7 (Figure 3.4).  The slope of the secondary quenching phase was 
substantially higher for the LUVs labeled with NBD-PE than with lipid 7.  This is probably 
because of a higher rate of unmediated transmembrane diffusion of sodium dithionite than that of 
cyclen 1 at their operating concentrations.  As can be seen, the fluorescence decay upon injection 
of Triton X-100 to LUVs labeled with lipid 7 and treated with 20 μM cyclen 1 was observed 
only at Triton X-100 concentration exceeding CMC (0.22 mM).
246
  However, in similar 
experiments with NBD-labeled LUVs, treated with 60 mM Na2S2O4, a substantial decrease in the 
fluorescence was observed after application of submicellar concentrations of the detergent.  
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Figure 3.4: Comparison of NBD-Dithionite and Cyclen 1-Lipid 7 Lipid Flip Monitoring 
Assay in the Presence of Variable Amounts of Triton X-100: (A) Kinetic monitoring of 
the fluorescence of NBD-labeled LUVs treated with 60 mM Na2S2O4 and varying 
amounts of Triton X-100.  From top to bottom the traces at 1500 s denote application of 
0.12, 0.17, 0.22, 0.36, 0.72, 1.45 and 2.9 (mM) Triton X-100.  Please, note a significant 
fluorescence quenching at 0.17 mM (below CMC) concentration of Triton X-100 (second 
trace from top). (B) Kinetic monitoring of the fluorescence of lipid 7-labeled LUVs 
treated with 20 μM cyclen 1 and varying amounts of Triton X-100.  From top to bottom 
the traces at 400 s denote 0.12, 0.22, 0.36, 0.72, 1.45, 2.9 (mM) Triton X-100.  Please 
note that the application of submicellar and micellar concentrations of Triton X-100 (two 
upper traces) resulted in a little loss of the fluorescence quenching.  In both figures, the 
traces were normalized by the subtraction of the residual fluorescence observed in the 
sample with highest amount of Triton X-100, and adjustment to 100% of the initial 
fluorescence values. 
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3.4.5 Physiological Compatibility of Cyclen 1 
To demonstrate the relative nontoxicity of cyclen 1, a series of cell growth inhibition 
assays were performed in the presence of cyclen 1 and sodium dithionite at concentrations 
relevant to the lipid flip monitoring assays.   
These assays revealed 10% inhibition of cell growth in the presence of 25 μM cyclen 1, 
compared to untreated cells, and approximately 5% cell growth inhibition compared to the cells 
treated with relevant amounts of DMSO (0.5%), consistent with physiological compatibility of 
this receptor (Figure 3.5A).  Treatment of the cells with the smallest concentration of sodium 
dithionite used in the lipid flip monitoring assays (10 mM) resulted in 15% growth inhibition.  
No morphological signs of cell damage or death was observed upon treatment with cyclen 1 
(Figure 3.5B). 
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Figure 3.5: Relative Non-Toxicity of Cyclen 1: (A) Results of growth inhibition 
assay (A2780 cell line) relative to untreated cells. (B) Images of A2780 cells 
from the growth inhibition assays: a) untreated cells, b) cells in the presence of 
0.5% DMSO; c) cells in the presence of 25 μM cyclen 1 and 0.5%DMSO. 
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 3.4.6 Applicability of New Methodology to the in Vitro Studies 
Finally, we demonstrated that the cyclen 1-based lipid flip monitoring assay can be 
utilized for in vitro studies.  We ran a series of confocal microscopy imaging experiments on 
HEK-293 cells.  These showed that the application of lipid 7 resulted in its rapid partitioning into 
the plasma membranes of the cells (Figure 3.6A-C).  Immediate application of cyclen 1 (20 μM) 
resulted in a complete fluorescence quenching consistent with the fact that all lipid 7 was 
accessible to the receptor.  However, the incubation of the cells with lipid 7 for 1 hour resulted in 
partial diffusion of lipid 7 into the internal membranes of cellular organelles.  Application of 20 
μM cyclen 1 in this case resulted in the fluorescence quenching of the outer cell membranes, but 
some residual fluorescence of the cell interior was still observed (Figure 3.6D-H).  Finally, we 
performed staining of the cells with lipid 5, which has high permeability to the membrane 
barriers (Figure 3.6I-O).  Unlike with lipid 7, no preferential staining of the outer membranes 
was observed but rather even distribution of the fluorescent lipid within the cellular interior.  A 
subsequent application of cyclen 1 resulted in the fluorescence quenching, which was complete 
after 15 minutes of incubation.  
These experiments demonstrate that a lipid 7-cyclen 1 pair provide a suitable pair for the 
lipid flip monitoring in in vitro experiments. The focus of our future studies will be a real-time 
monitoring of the flippase activity of Pgp, using a lipid 7-cyclen 1 lipid flip monitoring assay. 
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Figure 3.6: Confocal Microscopy Images of HEK-293 Cell Clusters (Caption on following page.) 
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Figure 3.6: Confocal Microscopy Images of HEK-293 Cell Clusters:   
 
Images A-C, D-H and I-O correspond to three distinct sets of cell clusters.   
 
(A) Brightfield image of the first set of cell clusters.  Consequent fluorescence 
images of the first set of clusters immediately after addition of lipid 7 (B) and upon 
addition of the quencher cyclen 1 (C) (the time interval between additions of lipid 7 
and cyclen 1 was less than 5 minutes).   
 
(D) Brightfield image of the second set of cell clusters. Consequent fluorescence 
images of the second set of clusters immediately after addition of the lipid 7 (E), after 
one hour of incubation with the lipid 7 (F), immediately (G) and 20 minutes (H) after 
the addition of the quencher cyclen 1.  
 
(I) Brightfield image of the third set of cell clusters. Consequent fluorescence images 
of the third set of clusters immediately after the addition of lipid 5 (J), after 30 
minutes (K) and one hour (L) incubation with the lipid 5;  immediately (M), 10 
minutes (N) and 20 minutes (O) after the addition of the quencher cyclen 1. 
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As with any other fluorometric methodology, the interpretation of the results obtained 
through the lipid 7-cyclen 1 lipid flip detection assay requires some care because of the possible 
effects of the non-natural cascade-blue label attached to the lipid molecule.  However, the highly 
anionic character of the cascade-blue label makes a flip of such conjugated lipids more difficult 
than that of the less polar natural lipids, and therefore no false-positive flippase activity should 
be detectable by this new methodology.  As an alternative, the hydrophobic lipid 5 in place of 
lipid 7 can be utilized, although with some limitations, to test the flip of less polar substrates. 
3.5 Conclusion 
In conclusion, we developed a new methodology for monitoring of lipid flip in both 
model and cell membranes.  This methodology relies on the micromolar concentrations of the 
fluorescence quencher cyclen 1 and therefore has better compatibility with the physiological 
conditions than the commonly utilized NBD-dithionite methodology which relies on high 
millimolar concentrations of sodium dithionite.  Unlike with NBD-dithionite assay, where the 
dithionite causes the irreversible quenching of the fluorescence of NBD-labeled lipid, cyclen 1 
forms a noncovalent complex with cascade-blue labeled lipid.  The noncovalent nature of such 
interactions provides a possibility for the reversal of binding through the displacement of the 
cascade-blue labeled lipid by a water-soluble substrate for cyclen 1.  Alternatively, the complex 
between cyclen 1 and lipid 7 can be decomposed through the enzymatic degradation of cyclen 1.  
The focus of our future studies will be a real-time monitoring of the flippase activity of Pgp, 
using a lipid 7-cyclen 1 lipid flip monitoring assay. 
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4.1 Abstract 
New pH-sensitive lipids were synthesized and utilized in formulations of liposomes 
suitable for controlled drug release.  These liposomes contain various amounts of NaCl in the 
internal aqueous compartments.  The release of the drug model is triggered by the application of 
an HCl co-transporter in exogenous physiologically relevant NaCl solution.  The HCl co-
transporter allows the uptake of HCl by liposomes to an extent that is proportional to the 
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transmembrane Cl
-
 gradient.  Therefore, each set of liposomes undergoes internal acidification, 
which ultimately leads to the hydrolysis of the pH-sensitive lipids and release of contents at the 
desired time.  The developed system releases the drug model in a stepwise fashion with the 
release stages separated by periods of low activity.  These liposomes were found to be insensitive 
to physiological concentrations of human serum albumin and to be non-toxic to cells at 
concentrations exceeding pharmacological relevance.  These results render this new drug release 
model potentially suitable for in vivo applications. 
4.2 Introduction 
 Biocompatible, pH-sensitive liposomes have recently become attractive vehicles for  
intracellular drug
247, 248
 and gene delivery.
249-253
  Targeted delivery of pH-sensitive liposomes to 
tumors, or infected sites with increased acidity was also proven successful.
254, 255
  Whereas 
reports on the applications of pH-sensitive liposomes for the intracellular delivery of therapeutic 
components are quite numerous, there are only few reports on the applicability of pH-sensitive 
liposomes for controlled drug release.
256-259
  The lack of applications for pH-sensitive liposomes 
for controlled drug release in blood plasma is due to the narrow range of intravascular pH, which 
is largely maintained by carbonic anhydrase.
260
  All literature precedence concerning pH 
sensitive liposomes reports a release of contents via an exogenous change in pH; and, to the best 
of our knowledge, a release of contents due to an internal liposome acidification has yet to be 
reported.  The internal acidification of liposomes, triggered by contact with blood plasma or 
other physiological fluid, provides a new model of a controlled drug release system, suitable for 
therapy of diseases such as diabetes.
261
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 In this paper, we report on the development of a new drug delivery system that provides a 
release of the drug model through a series of burst-like events.  The system is based upon the 
mixture of several sets of liposomes containing pH-sensitive lipids 8 or 9 in the bilayer 
membrane and various amounts of NaCl in the internal buffers.  The release of contents of 
liposomes is triggered by contact with  phosphate buffer saline (PBS) and/or application of HCl 
co-transporter 10 (Scheme 4.1).
262
  
 The HCl co-transporter 10 delivers HCl into the internal aqueous compartments of 
liposomes, making them more acidic.  Since the induced pH change is a function of the Cl
-
 
gradient, formulating liposomes with a preset internal NaCl concentration allows their future 
acidification to specific levels, ultimately causing a kinetically controlled decay of acetals 8 or 9; 
with the decay occurring fastest in the most acidic liposomes (Scheme 4.2).  The acetal-bearing 
molecules have previously been used in pH-sensitive drug delivery vehicles, and the kinetics of 
their hydrolysis makes them suitable for the controlled contents release.
263-265
 
Scheme 4.1: Compounds Utilized in the Present Study: 8 and 9: pH-sensitive 
synthetic lipids. 10: HCl-cotransporter triphenoxyacetamide. Cyclen 1: Synthetic 
receptor for HPTS dye. 
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4.3  Materials and Methods 
 4.3.1 General  
 The 
1
H NMR spectra were recorded on a Varian AS400 instrument operating at 400.130 
MHz or Varian Mercury instrument operating at 299.865 MHz. Chemical shifts are reported in 
ppm relative to the residual protonated solvent peak.  The 
13
C NMR spectra were recorded on the 
same instruments at 100.613 MHz and 75.408 MHz respectively and chemical shift values are 
reported in ppm relative to the solvent peak.  Both 
1
H and 
13
C spectra were taken in the same 
solvent and on the same instrument for each sample.  The low resolution mass spectra were 
recorded on a Micromass Q-TOF™ 2 instrument (Manchester, UK) using the electrospray 
technique (positive mode).  The samples were introduced into mass spectrometer using a flow 
rate of 10 μL/min, the needle voltage was set at 3500 V with ion source at 110°C and the cone 
time course 
30 mM  
NaCl 
pH 5.6 
pH 6.5 
 pH 7.2 
 pH 6.5 
  pH 7.2   pH 7.2 
HCl co-transporter  
100 mM  
NaCl 
 
0 mM 
NaCl 
Scheme 4.2: Stepwise Release of Liposome Contents Triggered by a Single Application 
of HCl Co-Transporter 10: Depending on the amounts of internal NaCl, liposomes are 
acidified by the action of 10 to variable extents and then release their contents upon 
hydrolysis at different times. 
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voltage at 35 V.  The high resolution mass spectra were recorded on a LCMS-IT-TOF (Shimadzu 
Corporation, Columbia MD) instrument using the electrospray technique (positive mode).  All 
spectrophotometric experiments were carried out on a Fluoromax 3 (Jobin-Yvon/Horriba) 
spectrophotometer.  The dynamic light scattering analysis of the liposome suspensions was 
carried out on the Malvern instrument (Malvern Zetasizer Nano Series, Malvern Instruments).  
The pH of solutions was monitored with a Corning 350 pH/ion analyzer, using a Ag/AgCl pH-
sensitive electrode (Accumet).  Chromatography was performed using 60-200 mesh silica 
purchased from Baker and 40-120 μm Sephadex G-75 purchased from Aldrich.  Thin layer 
chromatography was performed on Kieselgel 60 F254 and Uniplate
™
 Silica Gel GF silica-coated 
glass plates and visualized by I2.  High-pressure extrusion was performed on the Avanti
™
 mini-
extruder with a 0.1 μm polycarbonate membrane.  All chemicals and solvents were purchased 
from Aldrich, Sigma or Fluka.  Phospholipids were purchased from Avanti Polar Lipids. 
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 4.3.2 Synthesis  
Synthesis of pH-sensitive lipids 8 and 9 is outlined in Scheme 4.3. 
 
1-(2-bromo-1-(hexadecyloxy)ethoxy)hexadecane 8a.  To a solution of p-toluenesulfonic acid-
monohydrate (440 mg, 2.58 mmol) in acetone (200 mL) was added a small amount of Na2SO4.  
The resulting solution mixture stirred at room temperature for 30 minutes and was subsequently 
filtered to remove remaining Na2SO4.  The solvent of the filtrate was removed under diminished 
pressure affording a white residue.  The white residue was mixed with anhydrous THF (25 mL) 
and transferred to an addition funnel containing bromoacetaldehyde-diethyl acetal  (5.0 g, 0.0258 
mol) in anhydrous THF (100 mL).  The resulting solution mixture was added dropwise over 45 
minutes to hexadecanol (61.9 g, 0.255 mol), under N2 at 65°C.  The reaction mixture was stirred 
at reflux (68.8°C) for 3 days.  Then, the reaction mixture was cooled to room temperature and the 
solvent was removed under reduced pressure.  The residue was extracted with hexanes (250 mL) 
and cooled in an ice bath (0°C) to crystallize out any unreacted hexadecanol, which was filtered 
Scheme 4.3: Synthesis of Lipids 8 and 9: (8: R = C16H33, 9: R = Z-C8H16CH=CH-
C8H17) i) TosOH, hexadecanol or oleoyl alcohol, THF; ii) 2-(dimethylamino) 
ethanol, NaH, THF; iii) ethyl bromoacetate, diethyl ether; iv) aqueous KOH, 
MeOH:THF. 
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off.  The remaining organic filtrate was washed with saturated sodium bicarbonate and brine.  
The organic portions were combined, dried over MgSO4 and concentrated under diminished 
pressure producing an orange solid.  The crude solid was purified via flash column 
chromatography (silica gel, 20% CHCl3/Hexanes) affording a white solid (2.009 g, 0.0258 mol, 
13%).  
1
H NMR (300 MHz, CDCl3) δ 4.16 (td, J = 6.7, 0.8 Hz, 1H), 3.60 (d, 2H), 3.37 (t, 4H), 
1.65 (dd, J = 14.2, 6.9 Hz, 2H), 1.54 (s, 4H), 1.26 (s, 50H), 0.88 (t, J = 6.7 Hz, 6H).  
13
C NMR 
(400 MHz, CDCl3) δ 101.67, 67.18, 32.16, 29.93, 29.60, 26.34, 22.93, 14.35.  MS (ESI, high-
resolution) ([M+Na]):  613.3284, calcd for C34H69BrNaO2 m/z: 613.44. 
 
2-(2,2-bis(hexadecyloxy)ethoxy)-N,N-dimethylethanamine 8b.  NaH (60% in mineral oil, 
0.284 g, 0.0118 mol) was carefully mixed with hexanes (100 mL, deoxygenated) at room 
temperature to separate NaH from mineral oil.  After NaH settled, hexanes were removed by 
gravity filtration.  Anhydrous THF (20 mL) was added to the NaH and the resulting solution 
mixture was cooled to 0°C.  A solution of 2-(dimethylamino) ethanol (0.26 mL, 0.0258 mol) was 
added dropwise to the NaH solution.  The resulting solution stirred at 0°C under N2 for 30 
minutes.  The solution was warmed to room temperature and heated to reflux (70°C).  
Compound 8a (0.503 g, 0.852 mmol) in anhydrous THF (50 mL) was then added.  The resulting 
reaction mixture stirred at reflux (70°C) for 3 days.  The reaction mixture was slowly cooled to 
room temperature and subsequently cooled to 0°C.  A dropwise addition of H2O, to quench any 
remaining NaH, was continued until gas evolution ceased.  The reaction mixture was extracted 
with hexanes, washed with brine and concentrated under diminished pressure producing a yellow 
oil.  The crude oil was purified via flash column chromatography (silica gel, 7% MeOH/CHCl3 – 
20% MeOH/CHCl3) affording a yellow oil (0.031 g, 6%).  
1
H NMR (300 MHz, CDCl3) δ 4.61 (t, 
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J = 5.2 Hz, 1H), 3.90 – 3.21 (m, 8H), 2.57 – 2.41 (m, 2H), 2.27 (s, 6H), 1.65 (dd, J = 14.2, 6.9 
Hz, 2H), 1.54 (s, 4H), 1.26 (s, 50H), 0.88 (t, J = 6.7 Hz, 6H).  
13
C NMR (75 MHz, CDCl3) δ 
101.66, 71.85, 69.85, 67.14, 58.94, 45.97, 32.42, 32.15, 30.59, 29.84, 29.15, 26.50, 22.91, 14.33.  
MS (ESI, high-resolution) ([M+1]
+
):  598.6648, calcd for [C38H79NO3]
+
 m/z: 598.61. 
 
N-(2-(2,2-bis(hexadecyloxy)ethoxy)ethyl)-2-ethoxy-N,N-dimethyl-2-oxoethanaminium 8c.  
To a solution of 8b (0.015g, 0.0251 mmol) in diethyl ether (4.0 mL) was added 
ethylbromoacetate (0.040 g, 0.240 mmol).  The reaction mixture was stirred at room temperature 
for 19.5 hours.  The crude reaction solution was concentrated under diminished pressure.  The 
crude residue was purified via column chromatography (silica gel, 10 % MeOH/CHCl3) 
affording a white solid (0.012g, 0.0082 mmol, 71%).  
1
H NMR (300 MHz, CDCl3) δ 4.85 (s, 
2H), 4.54 (t, J = 4.7 Hz, 1H), 4.22 (dt, J = 10.8, 5.8 Hz, 4H), 3.99 (d, J = 4.3 Hz, 2H), 3.70 (s, 
6H), 3.64 – 3.24 (m, 4H), 1.70 (d, J = 18.4 Hz, 4H), 1.58 – 1.39 (m, 4H), 1.39 – 1.21 (m, 50H), 
1.00 (dd, J = 6.7, 3.6 Hz, 3H), 0.87 (t, J = 6.7 Hz, 6H).  
13
C NMR (75 MHz, CDCl3) δ 164.99, 
101.66, 71.85, 69.85, 67.14, 58.94, 45.97, 36.32, 32.42, 32.15, 30.59, 29.84, 29.15, 26.50, 22.91, 
14.33.  MS (ESI, high-resolution) ([M]
+
):  684.4030, calcd for [C42H86NO5]
+
 m/z: 684.65. 
 
2-((2-(2,2-bis(hexadecyloxy)ethoxy)ethyl)dimethylammonio) acetate 8.  A solution of KOH 
(0.8 mg, 0.0146 mmol) in H2O (0.3 mL) was added to a solution of 8c (0.002 g, 0.00292 mmol) 
in THF:MeOH (1:1, 1.0 mL).  The resulting reaction mixture was stirred at room temperature for 
15 minutes, then the solution was concentrated under reduced pressure.  The crude material was 
mixed with CH2Cl2 (2.0 mL) and then subsequently washed with H2O (2.0 mL).  The organic 
layer was concentrated under reduced pressure to give a white solid (1.8 mg, 0.00274 mmol, 
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95%).  
1
H NMR (300 MHz, CDCl3) δ 4.52 (m, 1H), 3.89 (d, J = 18.5 Hz, 2H), 3.75 – 3.26 (m, 
14H), 1.76 (m, 4H), 1.76 – 0.73 (m, 54H), 1.04 – 0.73 (m, 6H).  13C NMR (75 MHz, CDCl3) δ 
165.06, 101.02, 71.48, 67.26, 66.05, 63.24, 53.32, 32.15, 30.68, 29.46, 26.39, 22.92, 14.35.  MS 
(ESI, high-resolution) ([M+H]
+
):  656.4811, calcd for [C40H82NO5]
+
 m/z: 656.62. 
(Z)-1-(2-bromo-1-((Z)-octadec-9-en-1-yloxy)ethoxy))octadec-9-ene 9a.  To a solution of p-
toluenesulfonic acid-monohydrate (476 mg, 2.5 mmol) in acetone (200 mL) a small amount of 
Na2SO4 was added.  The resulting mixture was stirred at room temperature for 30 minutes and 
was subsequently filtered to remove Na2SO4.  The solvent of the filtrate was removed under 
diminished pressure affording a white residue.  The white residue was mixed with anhydrous 
THF (25 mL) and transferred to an addition funnel containing bromoacetaldehyde-diethyl acetal 
(3.0 g, 0.015 mol) in anhydrous THF (100 mL).  The resulting solution mixture was added 
dropwise over 45 minutes to oleyl alcohol (4.0 g, 0.15 mol), under N2 at 65°C.  The reaction 
mixture was stirred at reflux (68.8°C) for 3 days.  Then the reaction mixture was cooled to room 
temperature and the solvent was removed under reduced pressure.  The residue was extracted 
with hexanes (250 mL), washed with saturated sodium bicarbonate and brine.  The organic 
portions were combined, dried over MgSO4 and concentrated under reduced pressure producing 
an orange colored oil.  The crude oil was purified via column chromatography (silica gel, 20% 
CHCl3/Hexanes – 50% CHCl3/Hexanes) affording a lemon colored oil (7.26 g, 0.011 mol, 75%).  
1
H NMR (400 MHz, CDCl3) δ 5.51 – 5.28 (m, 4H), 4.65 (t, J = 5.4 Hz, 1H), 3.72 – 3.43 (m, 4H), 
3.38 (t, J = 9.8 Hz, 2H), 1.99 (dd, J = 13.3, 6.7 Hz, 8H), 1.58 (dd, J = 14.5, 6.8 Hz, 6H), 1.25 
(dd, J = 21.7, 9.4 Hz, 42H), 0.88 (t, J = 6.8 Hz, 6H); 
13
C NMR (300 MHz, CDCl3) δ 130.07, 
101.31, 66.67, 32.35, 31.57, 30.22 , 28.42, 26.94, 25.94, 22.43, 13.87.  MS (ESI, high-resolution) 
([M+Na]
+
):  663.4293, calcd for C38H73BrNaO2 m/z: 663.47. 
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2-(2,2-bis((E)-octadec-9-en-1-yloxy)ethoxy)-N,N-dimethylethanamine 9b.  Sodium hydride 
(60% in mineral oil, 2.68 g, 0.11 mol) was carefully mixed with hexanes (100 mL, 
deoxygenated) under N2 at room temperature to separate NaH from mineral oil.  After NaH 
settled, hexanes were removed via syringe and isopropanol was used to quench any NaH 
remaining in the removed hexanes solution and syringe.  Anhydrous THF (20 mL) was added to 
the NaH and the resulting solution mixture was cooled to 0°C.  A solution of 2-(dimethylamino) 
ethanol (1.87 mL, 0.019 mol) was added dropwise to the NaH solution.  The resulting solution 
was stirred at 0°C under N2 for 30 minutes.  Then the solution was warmed to room temperature 
and heated to reflux (68.8°C).  A solution of 9a (4.0 g, 0.0062 mol) in anhydrous THF (150 mL) 
was then added dropwise over a period of 30 minutes.  The resulting reaction mixture stirred at 
reflux (68.8°C) for 4 days.  The reaction mixture was slowly cooled to room temperature and 
subsequently cooled to 0°C.  Then, water was added dropwise to quench any remaining NaH, 
until gas evolution ceased.  The reaction mixture was extracted with hexanes, washed with brine 
and concentrated under reduced pressure producing a brown oil.  In some cases, the crude 
material was recrystallized from ethyl acetate and ethanol.  Final purification was carried out via 
column chromatography (silica gel, 20% CH3CN/CHCl3, 5% MeOH/CHCl3 – 15% 
MeOH/CHCl3) affording a brown oil (1.43 g, 36%).  
1
H NMR (400 MHz, CDCl3) δ 5.46 – 5.26 
(m, 4H), 4.61 (t, J = 5.2 Hz, 1H), 3.61 (dt, J = 8.9, 6.2 Hz, 4H), 3.57 – 3.40 (m, 4H), 2.55 (t, J = 
5.6 Hz, 2H), 2.31 (s, 6H), 1.99 (dd, J = 13.4, 6.8 Hz, 8H), 1.56 (dd, J = 13.9, 6.8 Hz, 4H), 1.27 
(d, J = 8.3 Hz, 44H), 0.88 (t, J = 6.7 Hz, 6H). 
 13
C NMR (300 MHz, CDCl3) δ 130.05, 101.08, 
71.30, 69.00, 66.65, 58.31, 45.37, 32.34, 31.63, 29.74 , 28.60, 26.93, 25.89, 22.42, 13.86.  MS 
(ESI, high-resolution) ([M+1]
+
):  650.6887, calcd for [C42H83NO3]
+
 m/z: 650.64. 
 97 
 
N-(2-(2,2-bis((Z)-octadec-9-en-1-yloxy)ethoxy)ethyl)-2-ethoxy-N,N-dimethyl-2-
oxoethanaminium 9c.  To a solution of 9b (250 mg, 0.384 mmol) in THF (25 mL) 
ethylbromoacetate  (0.128 mL, 1.15 mmol) was added.  The resulting reaction mixture was 
stirred under reflux (68.8°C) for 3 days.  The reaction mixture was cooled to room temperature 
and solvent was removed under reduced pressure.  Minor product removed as a solid via 
recrystallization from ethanol/ethyl acetate.  The filtrate was concentrated under reduced 
pressure producing sticky brown oil.  The oil was washed with a small amount of diethyl ether to 
remove any excess ethyl bromoacetate to give 217 mg (0.294 mmol, 77%) of 9c.  
1
H NMR (400 
MHz, CDCl3) δ 5.36 (d, J = 14.1 Hz, 4H), 4.87 – 4.37 (m, 5H), 3.77 – 3.35 (m, 16H), 2.20 (m, 
8H), 1.89 – 1.03 (m, 51H), 0.95 – 0.51 (m, 6H).  13C NMR (300 MHz, CDCl3) δ 156.80, 130.05, 
101.08, 69.00, 67.52, 65.87, 62.76, 60.42, 50.87, 49.20, 33.95, 31.92, 29.74, 28.60, 26.93, 25.89, 
22.42, 15.39, 13.86.  MALDI-TOF/MS ([M]): 736.9, calcd for [C46H90NO5]
+
 m/z: 736.68. 
 
2-((2-(2,2-bis((Z)-octadec-9-en-1-yloxy)ethoxy)ethyl)dimethyl ammonio)acetate 9.  To a 
solution of 9c (210 mg, 0.285 mmol) in MeOH:THF:Brine (1:1:1) was added KOH (0.096 g) at 
room temperature.  The reaction mixture was sonicated for 30 minutes, filtered and concentrated 
under diminished pressure affording a beige colored oil (165 mg, 0.233 mmol, 82%).  
1
H NMR 
(300 MHz, CDCl3) δ 5.15 (ddt, J = 42.0, 12.2, 6.1 Hz, 4H), 4.92 – 4.75 (m, 2H), 4.63 (d, J = 36.1 
Hz, 1H), 4.37 – 3.43 (m, 18H), 3.07 – 1.89 (m, 4H), 2.84 – 1.89 (m, 4H), 2.21 – 1.64 (m, 4H), 
1.76 – 1.32 (m, 12H), 1.44 – 1.32 (m, 6H), 1.44 – 0.25 (m, 29H), 0.89 (t, J = 6.7 Hz, 6H).  13C 
NMR (300 MHz, CDCl3) δ 156.80, 130.05, 101.08, 63.11, 50.90, 49.20, 33.97, 31.91, 29.74, 
28.60, 26.93, 25.89, 22.42, 15.39, 13.86.  MALDI-TOF/MS ([M+H]): 708.9, calcd for 
[C44H86NO5]
+
 m/z: 708.65. 
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Triphenoxyacetamide 10 was synthesized according to the literature procedure.
262
 
Cyclen tetraurea 1 was synthesized as described.
237
 
 4.3.3 Liposome Preparation for pH-Controlled Release Studies   
 Egg yolk L-α-phosphatidylcholine (EYPC, ethanol solution, 27 µL, 6.58 µmol), 1,2-
dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE, ethanol solution, 500 µL, 6.72 µmol), and 
lipid 8 or lipid 9 (solution in CHCl3/MeOH/EtOH, 435 µL, 14.1 µmol) were combined and 
dissolved in CHCl3 (5 mL), MeOH (0.5 mL) and EtOH (0.5 mL), then concentrated under 
reduced pressure in the round-bottom flask to produce a transparent film (25 % EYPC, 25% 
DOPE, 50% lipid 8 or lipid 9).  The film was dried under high vacuum for 4 hours, and was 
subsequently hydrated for 1 h in 800 µL of HPTS sodium phosphate buffer (100 µM HPTS, 100 
mM NaCl or 75 mM Na2SO4, 10 mM sodium phosphate, pH 7.0).  During the hydration process 
the suspension was exposed to 10 freeze-thaw cycles (MeOH/dry ice, 45°C water bath).  The 
resulting suspension was submitted to 21 high-pressure extrusions at room temperature through a 
0.1 µm membrane affording liposomes.  The liposomes were purified via size-exclusion 
chromatography (Sephadex G-75 was used as a solid phase, the same buffer as used for the 
hydration of liposomes except HPTS, was used as an eluent).  The liposomes eluted as a cloudy 
solution that appeared light blue under UV light (2.0 mL).  For the incubation and fluorimetric 
experiments, the collected liposomes were diluted in sodium phosphate buffer (100 mM NaCl, 
10 mM sodium phosphate, pH 4-7.0) to a final concentration of 500 µM. 
 4.3.4 Fluorescence Studies of pH-Controlled Release of Liposome Contents  
 In a typical experiment, the suspension of liposomes (10.0 mL at 500 µM concentration 
of total lipid) in sodium phosphate buffer (100 mM NaCl, 0-10 μM triphenoxyacetamide 10, 10 
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mM sodium phosphate, pH 4-7.0) was stirred at room temperature.  Aliquots of 2.0 mL were 
analyzed at timepoints of initial, one hour, four hours, 11 hours and 24 hours.  All flourometric 
experiments at each timepoint were kept consistent.  The 2.0 mL sample was loaded in a 
thermostated spectrophotometric cell.  The liposome suspension was stirred at 25°C during the 
course of analysis.  The emission of HPTS at 511 nm was monitored with concurrent excitation 
at 405 and 460 nm.  The emission and excitation slits of the spectrophotometer were set at 5 nm, 
time increments were set at 2.0 s, and integration time  was set at 0.5 s.  The total time of each 
experiment was 600 s.  An injection of  cyclen tetraurea 1 (20 μL of 1.0 mM solution in DMSO) 
was made at 60 s, followed by the injection of Triton X-100 (40 μL of 25% wt/v in Millipore 
H2O) at 500 s. 
 4.3.5 Liposome Preparation for Dynamic Light Scattering Studies   
 The preparations of liposomes were similar to those for pH-controlled release studies.  
For these preparations the use of HPTS dye was omitted and liposomes were not passed through 
a Sephadex column.  The liposome suspension was transferred from an extruder syringe into a 
vial, after 21 extrusions.  The liposomes were diluted in sodium phosphate buffer (100 mM 
NaCl, 10 mM sodium phosphate, pH 7.0) to a final conetration of 500 µM in the total lipid. 
 4.3.6 Dynamic Light Scattering Studies   
 Liposome suspensions (2.0 mL) were analyzed in a disposable cuvette at 25°C on a 
Malvern Zetasizer Nano Series Instrument.  An initial run was performed to determine the size of 
the liposomes.  Then human serum albumin (HSA, 100 mg) was added to the liposome 
suspension and the resulting suspension was mixed by inverting.  All DLS runs consisted of 10 
separate measurements of Z average obtained every four minutes, with the average value being 
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reported for each experiment. 
 4.3.7 MTS Cell Proliferation Assay 
 B16F10 tumor cells were employed to evaluate liposomes for effects on cell viability 
with the MTS [(3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy-phenyl)-2-(4-sulfophenyl)-
2H-tetrazolium] assay.  The MTS assay is a colorimetric method for determining the number of 
viable cells by measuring the activity of enzymes that reduce MTS in the presence of phenazine 
methosulfate to formazan, giving a purple color. After the cells (10
4 
cells/well) were cultured in a 
96-well plate for 3 days in the presence of various concentrations of small unilamellar vesicles 
(SUVs), MTS solution (Promega) was added and the absorbance at 490 nm was recorded using a 
96-well plate reader (Molecular Devices Thermomax Plate Reader, Rockville, MD).  Results are 
presented as the mean ± S.E. The student t-test was used for detection of differences.  
Transmission images of the cells were obtained on Olympus IX50 microscope (Olympus Inc., 
Tokyo, Japan), using 20x magnification. 
4.4 Results and Discussion 
 4.4.1 Formulation of Liposomes  
 In order to develop an operational drug delivery system, an appropriate lipid composition 
for the formulation of the liposomes had to be determined.  The proper liposomal composition 
would allow us to accomplish the following: 1) to encapsulate the drug model in liposomes and 
2) to release this model upon hydrolysis of acetal groups of lipids 8 or 9.  8-Hydroxypyrene-
1,3,6-trisulfonic acid (HPTS) was chosen as the drug model.
266
  When encapsulated in 
liposomes, this pH sensitive dye can detect internal pH changes through the change in 
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fluorescence of its protonated and deprotonated forms; furthermore, the release of the dye can be 
monitored through exogenous application of cyclen-tetrathiourea compound 1.
237
  This 
membrane-impermeable compound binds to HPTS dye in PBS with submicromolar affinity and 
high selectivity, and quenches 90% of its fluorescence.
237
  The typical calcein and 
carboxyfluorescein release assays
267, 268
 cannot be used for these purposes, as a consequence of 
the high (100 mM) concentration of dye required for the fluorescence self-quenching.  At these 
concentrations, the dyes with pKa’s of 6.7-7.0
269
 would act as buffering compounds and preclude 
acidification of liposomal interior during the uptake of HCl.  At the same time, liposomes, loaded 
with HPTS dye at low (100 μM) concentration can be readily acidified through co-transport of 
HCl.  A different technique for monitoring of contents release, that relies on the encapsulated 
mixtures of HPTS and p-xylene-bis-pyridinium bromide  (DPX)
256, 270, 271
 was also proven 
unsuitable for our purposes.  In this technique, for optimal quenching of the HPTS fluorescence, 
DPX has to be used at 50 mM concentration, which creates 100 mM internal concentration of 
bromide anion. Bromide is also a substrate for the HCl co-transporter 10 (unpublished data); 
therefore, the efflux of HBr from liposomes would nullify the effects produced by the influx of 
HCl.   
 The proper lipid composition was determined by monitoring of the extent of HPTS 
encapsulation.  In a typical experiment, a 2 mL aliquot of the stock suspension of liposomes (see 
experimental) was transferred into a fluorimetric cell, and 10 μL of 1 mM solution of compound 
cyclen 1 in DMSO was injected, followed by the injection of the detergent Triton X-100.  The 
extent of fluorescence quench upon injection of compound cyclen 1 was attributed to the portion 
of the dye remaining outside the liposomes.  The extent of fluorescence quenching after the lysis 
of liposomes with Triton X-100 was due to the dye encapsulated in the aqueous compartments of 
 102 
 
liposomes and therefore not accessible to compound cyclen 1 prior to lysis.  We found that 
neither lipid 8, nor lipid 9 were capable of encapsulating HPTS dye when utilized in their pure 
forms.  Presumably, the two lipids did not form liposomes at all; consequently, a more complex 
mixture of lipids was used as an alternative.  
 We found that the most effective encapsulation of HPTS dye occurred for the lipid 
formulations comprising 25 mol% of EYPC, 25 mol% of DOPE and 50% of lipid 8 or 9.  
 4.4.2 pH-Dependent Release of Contents  
 First, we demonstrated that liposomes containing lipids 8 and 9 were actually pH 
sensitive.  To accomplish this, two sets of liposomes formulated with lipid 8 and lipid 9, were 
prepared in PBS (100 mM NaCl, 10 mM Pi, pH = 7.0, 100 μM HPTS inside).  Then, these 
liposomes were incubated in HPTS-free PBS at pH 4 and 6, respectively, for various periods of 
time, as detailed in the experimental section.  After incubation, liposomes were transferred into a 
fluorimetric cell, and the fluorescence of HPTS was monitored (ex 405 nm, em 510 nm).  During 
each experiment, a DMSO solution of compound cyclen 1 was injected, followed by lysis of 
liposomes with Triton X-100 at 500 s.  
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 Liposomes prepared from lipid 9 were stable at neutral pH for only about 1 hour and 
displayed an instant collapse at reduced pH.  However, liposomes prepared from lipid 8 were 
stable at neutral pH for extensive periods of time and showed pH-dependent contents release at 
lower pH (Figure 4.1A).  Thus, at pH 6, liposomes formulated with lipid 8 did not exhibit a 
significant release of HPTS for the first 24 hours, yet, a rapid release of HPTS from these 
liposomes was observed in the next 12 hours (Figure 4.1B).  The same liposomes, when 
incubated in PBS at pH 4, were stable for 4 hours, and released their entire contents after 8 hours 
of incubation.  These experiments demonstrated that liposomes prepared from lipid 8 were 
indeed pH sensitive.  A rather quick then gradual release of the dye is consistent with rapid 
liposome to micelle transition, caused by a buildup of amphiphilic hexadecanol in the membrane 
of liposomes upon hydrolysis of lipid 8.
272, 273
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Figure 4.1: Release of HPTS Dye from Liposomes Prepared from 25 mol% EYPC, 
25 mol% DOPE and 50 % Lipid 8, Monitored by Quenching (ex 405 nm, em 510 
nm) of HPTS Fluorescence by 10 μM Exogenous Cyclen 1: (A) External pH is set at 
4.0. Traces from top to bottom denote: 1) 0 hours of incubation; 2) 4 hours of 
incubation; 3) 8 hours of incubation. (B) External pH is set at 6.0. Traces from top to 
bottom denote: 1) 0 hours of incubation; 2) 12 hours of incubation; 3) 24 hours of 
incubation; 4) 36 hours of incubation. Time events in the course of experiments: 60 
sec – cyclen 1 was added; 500 sec – 0.5% Triton X-100. 
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 4.4.3 Release of HPTS from Asymmetric Liposomes 
 After revealing that formulations of liposomes containing lipid 8, respond to the external 
change in pH, we demonstrated that the variations in internal pH could also affect their stability.  
In order to achieve this task, two populations of liposomes were prepared with an identical lipid 
composition (25 mol% DOPE, 25 mol% EYPC and 50 mol% lipid 8) but various aqueous 
internal contents.  The first set was formulated with PBS (100 mM NaCl, 10 mM Pi, pH = 7, 100 
μM HPTS), and the second set of liposomes was formulated with sodium sulfate instead of 
sodium chloride (75 mM Na2SO4, 10 mM Pi, pH = 7, 100 μM HPTS).  Seventy-five mM Na2SO4 
was used in place of 100 mM NaCl to ensure isoosmolality of the internal solution of liposomes 
to that of the external PBS.
274
  
 Both populations of liposomes were suspended in PBS followed by the subsequent 
addition of 10 μM compound 10.  Liposomes containing Na2SO4 demonstrated rapid 
acidification of their internal compartments to a pH of approximately 5.6, as evidenced by 
change in the fluorescence of HPTS (Figure 4.2A, lower trace).
266
  After acidification, the 
internal pH did not change significantly until liposomes were lysed with Triton X-100, after a 
period of 1 hour.  A small increase in the internal pH (~ 0.1 pH units) observed during this time 
was most likely due to insignificant decomposition of liposomes and subsequent release of the 
dye.  Lysis of liposomes resulted in a complete release of HPTS into the external buffer, which 
caused the increase of pH back to 7.  Application of compound 10 to the suspension of NaCl-
containing liposomes did not produce a change in the internal pH due to the lack of Cl
-
 gradient 
across the bilayer membrane (Figure  4.2A, upper trace). 
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Figure 4.3: Contents Release from Symmetrical (NaClin/out) and Asymmetrical 
(Na2SO4in/NaClout) Liposomes, Formulated with Lipid 8: (A) Fluorimetric kinetic 
experiments for contents release from symmetrical liposomes. HPTS emission (ex = 
405, em = 510) was monitored as function of time. Prior to the experiments, 
liposomes were incubated in PBS with 10 μM compound 10 for various periods of 
time as denoted in the inset. (B) The same experiments with asymmetrical liposomes. 
Time events: 60 s: 10 μM compound cyclen 1; 500 s: 0.5% Triton X-100. 
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Figure 4.2: pH Relationships for Triphenoxyacetamide 10 and HPTS Dye: (A) 
Change in the internal pH of liposomes upon application of triphenoxyacetamide 10. 
Upper trace at 2000 s corresponds to symmetrical liposomes (100 mM NaCl, 10 mM 
Pi inside and outside). Lower trace corresponds to asymmetrical liposomes (75 mM 
Na2S04, 10 mM Pi inside, 100 mM NaCl, 10 Pi outside). The pH was monitored as a 
function of Irel,  where Irel = I460/I405. Time events: 60 s – 10 μM triphenoxyacetamide 
10 added, 3660 s – 0.5% liposomes lysed with 0.5% Triton X-100. (B) Calibration 
plot relating Irel of HPTS to the actual pH of the solution. Inset shows linear fit 
equation for the low pH (pH < 6.5) and quadratic fit equation for the high pH (pH > 
6.5). 
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 After verifying that liposomes that are under a Cl
-
 gradient can be acidified by application 
of triphenoxyacetamide 10, we incubated both populations of liposomes in PBS for various 
periods of time.  At the end of each period, the extent of contents release was analyzed 
fluorimetrically (Figure 4.3).  The symmetrical liposomes (NaClin/out) did not show substantial 
release of the dye for at least four days, but liberated all their contents after 6.5 days.  At the 
same time, asymmetrical liposomes (Na2SO4in/NaClout) were stable for only 13 hours, and 
released their contents almost completely after 2.5 days. 
 Finally, we decided to prepare a mixture of both populations of liposomes and 
consequently analyze the contents release using this model (Figure 4.4).  As can be seen, the 
release of contents illustrated an intricate profile, wherein the periods of inactivity were followed 
by rather rapid release of HPTS.  A plateau at ~96 hours of incubation corresponds to the time 
segment, where the entire contents of the asymmetrical subpopulation of liposomes was released, 
and the symmetrical liposomes did not begin to decompose yet.  This observation suggests that 
for the preferred concentration of liposomal suspension, there was no transfer of hexadecanol 
from the micelles into the intact liposomes, and no hexanol-induced fusion of the hydrolyzed and 
intact membranes took place; two populations of liposomes released their contents independently 
from each other.  This observation is similar to that reported for the oleoyl alcohol effects on the 
stability of pH-sensitive liposomes.
275
  Although the initial period of inactivity for the 
aforementioned mixture of liposomes was approximately 12 hours, a faster release of the 
contents could be achieved through addition of a more flexible and hence more pH-sensitive 
lipid 9 into the formulation of liposomes. 
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 4.4.4 Biocompatibility 
Although this work did not involve any in vivo studies, the principal biocompatibility of 
these pH-sensitive liposomes was demonstrated. It is known that liposomes with a net positive 
charge on their surface are rapidly cross-linked with serum albumin within blood plasma and 
then cleared from circulation.
276, 277
  Dynamic light scattering (DLS) studies can be used for 
monitoring of the relative size of particles in the presence of human serum albumin (HSA).
90, 278, 
279
  We performed a series of DLS experiments on four types of liposomes.  Two sets were 
formulated using lipids 8 and 9, and two other sets were formulated with cationic precursors 8c 
and 9c.  The latter formulations were used as positive controls, since they were expected to 
change in size upon interactions with HSA.  
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Figure 4.4: Contents Release from the 1:1 Mixture of Two Sets of Liposomes, 
Formulated with Lipid 8: Set 1: 100 mM NaCl inside, 10 mM Pi, pH = 7, 100 μM 
HPTS. Set 2: 75 mM Na2SO4 inside, 10 mM Pi, pH = 7, 100 μM HPTS. Both sets 
were incubated in the HPTS-free PBS (100 mM NaCl, 10 mM Pi, pH = 7, 10 μM 
triphenoxyacetamide 10). (A) Fluorimetric kinetic experiments for contents release. 
From top to bottom at 300 s traces denote the following incubation times: 0, 6, 12, 18, 
24, 30, 42, 48, 60, 72, 84, 96, 120 and 168 hours, respectively. Time events: 60 s: 10 
μM compound cyclen 1; 500 s: 0.5% Triton X-100. (B) Percentage of contents release 
from the kinetic experiments, as a function of incubation times. 
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  In the absence of HSA all four formulations of liposomes were approximately 100 nm in 
diameter (Figure 4.5A), consistent with the extrusion of liposomes through 100 nm pores.  
However, incubation of these liposomes with HSA for 40 minutes resulted in a formation of 
particles of varying sizes in all four experiments.  Small size particles of about 6 nm were 
observed immediately upon addition of HSA, which is consistent with the size of human serum 
albumin globules.
280
  Larger size particles with the diameter of 300-1000 nm were detected 
immediately upon addition of HSA to the suspensions of liposomes formulated with cationic 
lipids 8c and 9c (Figure 4.5B, two bottom traces).  No such immediate formation of larger 
particles was observed during the first 20 minutes for lipids 8 and 9.  However, a small amount 
of larger aggregates with the diameter of ~ 800 nm became detectable for lipid 9 after 40 minutes 
(Figure 2B, third trace from the bottom).  Formulation with lipid 8 did not undergo any 
noticeable changes during this time (Figure 4.5B, upper trace).  These results suggest that at 
least liposomes formulated with lipid 8 do not form large aggregates in the presence of HSA, and 
therefore potentially suitable for the in vivo applications. 
 
  
1 10 100 1000 10000
diameter, nm
1 10 100 1000 10000
diameter, nm
Figure 4.5: Dynamic Light Scattering Experiments on the Liposomes Formulated with 
Lipids 8 or 9 and their Cationic Precursors 8c and 9c in the Absence (stack A) and in the 
Presence (stack B) of Human Serum Albumin: In both stacks, traces from top to bottom 
denote liposomes formulated with lipids: 1) 8; 2) 9; 3) 8c; 4) 9c. 
 
B A 
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 4.4.5 Cytotoxicity of Liposomal Formulations  
To show general non-toxicity of liposomal formulations, we conducted cell viability 
assays with liposomes, formulated with lipid 8 and compound 10.  Since compound 10 is a HCl 
co-transporter, it was possible that this compound exhibits certain cytotoxicity as other natural 
HCl co-transporters (e.g.,  prodigiosin).
281, 282
  However, when B16F10 tumor cells were 
incubated with the synthetic liposome mixture, at concentrations exceeding 1 mM (total lipid 
concentration) and compound 10 at 20 μM concentration, cell proliferation was indistinguishable 
from the negative control (Figure 4.6A).  In contrast, the positive control experiment, in which 
the cells were incubated with a potent cytotoxin curcumin,
283, 284
 resulted in virtually complete 
cell death, signifying that the cell culture responded to the cytotoxic substances.  No 
morphological signs of cell change or death were observed upon treatment of B16F10 tumor 
cells with the aforementioned liposomes (Figure 4.6B).
285
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Figure 4.6: Viability Studies of B16F10 Tumor Cells: (A) Liposomes with lipid 8 had no 
effect on the viability of B16F10 tumor cells. B16F10 tumor cell viability in the presence 
of various concentrations of liposomes or 10 g/mL curcumin (positive control, PC, for 
72 hours. The sign “**” indicates  p  0.01 determined by the Student t-test. (B) Cell 
images in the absence (panel a) and in the presence of liposomes with lipid 8 and HCl co-
transporter 10 (panels b and c correspond to the total lipid concentration of 0.58 mM and 
1.16 mM, respectively). Cell image upon treatment with curcumin (panel d).  
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4.5 Conclusions 
 In conclusion, we developed a new controlled drug release system that is based on a 
mixture of several populations of pH-sensitive liposomes.  Unlike other pH-responsive drug 
delivery systems that required exogenous acidification for release, this system was initiated 
through the acidification of the internal aqueous compartments of liposomes upon the contact 
with physiologically relevant solution of NaCl.  A degree of such acidification was controlled by 
the internal concentrations of NaCl and allowed to release the contents of liposomes in 12 hours 
through 7 days.  The drug delivery system, based on lipid 8 was shown to be not sensitive to the 
physiological concentrations of HSA, and non-toxic at total lipid concentrations of up to 1 mM 
and concentrations of compound 10 up to 20 μM.  Our future studies will focus on extension of 
the time range for the controlled drug release, as well as on the in vivo applicability of this new 
drug delivery system.  
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Chapter 5 
 
Conclusions and Future Work 
 
5.1 Summary of this Work 
This work focuses on the development of cyclen-thiourea based receptors which have a 
high affinity for fluorescent dyes.  Specifically, our research group designed and synthesized a 
receptor we named cyclen 1 which has a high affinity for pyrene-based dyes.  These receptor-
fluorescent dye pairs provide a non-invasive, physiologically compatible, accurate methodology 
suitable for the study of biomembrane leakage and lipid flip events, which are both critical 
processes in cellular membrane activity.  The approaches described within this work address 
intrinsic deficiencies that have been observed in widely accepted protocols. These undesirable 
interactions with the bilayer membranes have arisen from the small nature of the molecular probe 
compounds utilized in these protocols.  This newly proposed macromolecular approach enables 
the fluorometric detection of biomembrane events, which are in high demand by the biochemical 
community and a target for developmental pharmaceuticals.  These receptor-dye complexes 
provide useful insight into biomembrane processes including molecular transport which is 
monitored by our novel membrane leakage assay as well as lipid translocation utilizing the lipid 
flip assay.  Our research group has also formulated and developed a newly-designed drug 
delivery system which can be monitored using the cyclen 1–pyranine membrane leakage assay.  
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Overall, this new macromolecular receptor-dye complexation has great potential for application 
in multiple fields including chemistry, biochemistry, pharmacology and cell biology.   
5.2 Future Directions 
5.2.1 Further Development and Application of the Membrane Leakage Assay 
Design of additional cyclen-based receptors. 
The design and synthesis of the receptor cyclen 1, which has a high affinity to pyranine 
dye under near-physiological conditions and is impermeable to the bilayer membrane, has led to 
a novel membrane leakage assay that is fully compatible with the pH-stat assay.  This assay 
enables the distinction between ion transport and membrane leakage within a single set of 
experiments.  Although the newly designed receptor-dye complexes present advancements over 
currently utilized membrane leakage assays, there are some limitations in the applicability of 
cyclen 1 to biomembrane assays.  These limitations primarily arise from its quenching efficiency 
and low solubility in aqueous medium.  Hence, it would be advantageous to pursue the synthesis 
of a new receptor with a higher quenching affinity.  A higher quenching efficiency for the 
receptor-dye complex could potentially lead to lower operating concentrations of dye, thus 
enabling a more physiologically compatible study.  Therefore, future studies will focus on the 
development and synthesis of new cyclen-based 
receptors.  Specifically, it has been shown that p-
xylene-bis-pyridinium bromide (Figure 5.1, DPX) can 
quench almost 100% of HPTS fluorescence.
25
  We 
hypothesize that the inclusion of the charged DPX 
moiety could possibly increase the solubility of the Figure 5.1: Structure of DPX 
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receptor in aqueous medium, while potentially improving the quenching efficiency of the 
receptor.  Therefore, in order to improve these characteristics, a new cyclen-based derivative 
which incorporates DPX will be synthesized.  Once this compound has been synthesized it will 
be characterized and applied to the membrane leakage assay.  Within this study, we have also 
shown some limited applicability of cyclen 1-pyranine complexation to the detection of 
endovesiculation, and we are therefore also hopeful that an improved DPX fluorescence 
quencher will also be compatible with the endovesiculation assay.   
Assessment of pore sizes through the new membrane leakage assay.  
The currently developed membrane-leakage assay provides a possibility to distinguish 
between selective ionophores and large pores.  We believe that the same assay can be utilized to 
assess the size of the pore by measuring the kinetics of HPTS leakage.  At micromolar 
concentration, the leakage rate of HPTS is determined by free diffusion through the pores.  The 
pore size comparable with the diameter of HPTS (~ 8 Å) should limit this diffusion rate due to 
the steric hindrance (Scheme 5.1).  The rate constants for HPTS leakage will be plotted as a 
function of pore size, allowing the leakage rate constant to be used to calculate the pore size 
formed by compounds with unknown characteristics.  This assay is limited by the size of HPTS 
molecule, meaning, any pore smaller than the HPTS will be inaccessible.  We will expand the 
limits of the pore size assessment by employing experiments with dyes of smaller size (ANTS, ~ 
5 Å for example).  For calibration, the membrane leakage experiments will be performed with 
LUVs loaded with HPTS in the presence of the pore-forming peptides magainin,
286
 
alamethicin,
287
 and hemolysin,
288
 whose pore characteristics are well-established.  The sizes of 
the pores in the presence of LUVs formulated with ceramides can be incrementally adjusted by 
varying the ceramide concentrations relative to the other lipid ratios within the LUVs.
289
  If this 
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method turns out to be valid, the pore size assessment assay will become a valuable tool to the 
biochemical community, as there is no such assay generally adopted for the spherical bilayers.
290
  
(An assay described in literature operates with LUVs containing high calcein at high 
concentration.  Due to these reasons, this assay is not really useful for pore size assessment.)  
Additionally, electrophysiological pore size assessments utilize the membrane model under 
different conditions.
291
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Scheme 5.1: Proposed calibration study for assessment of pore sizes. HPTS 
leakage rate constants will be plotted as function of pore size formed from 
known pore-forming compounds. 
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5.2.2 Further Development and Application of the Lipid Flip Monitoring Assay 
In the second part of this work, the receptor-pyranine complexation
185
 was applied to the 
development of a new methodology for monitoring of lipid flip in both model and cell 
membranes.  This methodology relies on the micromolar concentrations of the previously 
synthesized fluorescence quencher cyclen 1 and has demonstrated potential for reversible 
quenching with a newly synthesized cascade-blue labeled lipid.
186
  Therefore, we show that the 
new methodology has better compatibility with the physiological conditions than the commonly 
utilized NBD-dithionite methodology, that relies on high millimolar concentrations of sodium 
dithionite and the irreversible quenching of the fluorescence of NBD-labeled lipid by 
dithionite.
168, 169, 292
  Furthermore, wild type human P-glycoprotein, (Pgp), which is a known 
flippase,
171
 facilitates lipid flip to a lesser extent then Pgp treated with the reducing agents,
172
 
whereas the activity of human scramblase protein is suppressed by reducing reagents.
173
  These 
examples demonstrate that dithionite may affect the flipping activity of enzymes in a dual way 
and, therefore, cannot be used in the real time monitoring experiments.  Hence, the focus of our 
future studies will be a real-time monitoring of the flippase activity of Pgp, using the newly 
developed lipid flip monitoring assay.  Lastly, since we were able to utilize the fluorescently 
labeled lipids for the in vitro studies, the synthesis of a variety of lipids with differing 
hydrophobicities could provide lipids with differing time-intervals of lipid flip.  This variation 
could be beneficial in the real-time monitoring of flippases, floppases and scramblases. 
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5.2.3 Further Development and Application of the pH-Sensitive Controlled Drug Release 
System 
In the last part of this work a new controlled drug release system was developed.  This 
system is based on a mixture of several populations of pH-sensitive liposomes containing NaCl 
that lyse upon internal acidification.  The degree of acidification was controlled by the internal 
concentrations of NaCl which allowed the release of the contents of liposomes, from 12 hours 
through 7 days, upon the application of exogenous HCl co-transporter 10.  The drug delivery 
system, based on lipid 8 was shown to be not sensitive to the physiological concentrations of 
HSA, and non-toxic at total lipid concentrations of up to 1 mM and concentrations of compound 
10 up to 20 μM.  Our future studies will focus on extension of the time range for the controlled 
drug release.  To begin, this will be accomplished through the syntheses of a wide range of 
additional hydrolysable lipids.  Additionally, we will also focus on the in vivo applicability of 
this new drug delivery system.   
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